Interleukin-3	B-protein
expression	O
by	O
activated	B-cell_type
T	I-cell_type
cells	I-cell_type
involves	O
an	O
inducible	O
,	O
T-cell-specific	B-protein
factor	I-protein
and	O
an	O
octamer	B-protein
binding	I-protein
protein	I-protein
.	O

Interleukin-3	B-protein
(	O
IL-3	B-protein
)	O
is	O
exclusively	O
expressed	O
by	O
activated	B-cell_type
T	I-cell_type
and	O
natural	B-cell_type
killer	I-cell_type
cells	I-cell_type
,	O
a	O
function	O
that	O
is	O
tightly	O
controlled	O
both	O
in	O
a	O
lineage-specific	O
and	O
in	O
a	O
stimulation-dependent	O
manner	O
.	O

We	O
have	O
investigated	O
the	O
protein	O
binding	O
characteristics	O
and	O
functional	O
importance	O
of	O
the	O
ACT-1-activating	B-DNA
region	I-DNA
of	O
the	O
IL-3	B-protein
promoter	O
.	O

This	O
region	O
binds	O
an	O
inducible	O
,	O
T-cell-specific	B-protein
factor	I-protein
over	O
its	O
5	B-DNA
'	I-DNA
end	I-DNA
,	O
a	O
site	O
that	O
is	O
necessary	O
for	O
the	O
expression	O
of	O
IL-3	B-protein
in	O
the	O
absence	O
of	O
other	O
upstream	O
elements	O
.	O

Over	O
its	O
3	B-DNA
'	I-DNA
end	I-DNA
,	O
it	O
binds	O
a	O
factor	O
that	O
is	O
ubiquitously	O
and	O
constitutively	O
expressed	O
.	O

This	O
factor	O
is	O
Oct-1	B-protein
or	O
an	O
immunologically	B-protein
related	I-protein
octamer-binding	I-protein
protein	I-protein
,	O
and	O
it	O
plays	O
a	O
role	O
in	O
coordinating	O
the	O
activity	O
of	O
several	O
regulatory	B-DNA
elements	I-DNA
.	O

These	O
characteristics	O
make	O
the	O
ACT-1	B-DNA
site	I-DNA
analogous	O
to	O
the	O
activating	O
ARRE-1	B-DNA
site	I-DNA
in	O
the	O
IL-2	B-DNA
promoter	I-DNA
.	O

Furthermore	O
,	O
and	O
despite	O
a	O
lack	O
of	O
sequence	O
homology	O
,	O
the	O
promoters	O
of	O
IL-3	B-protein
and	O
IL-2	B-protein
share	O
an	O
organizational	O
pattern	O
of	O
regulatory	O
elements	O
that	O
is	O
likely	O
to	O
be	O
important	O
for	O
the	O
T-cell-specific	O
expression	O
of	O
these	O
genes	O
.	O

From	NULL
www	NULL
.	NULL

bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

Interleukin-3	NULL
Expression	NULL
by	NULL
Activated	NULL
T	NULL
Cells	NULL
Involves	NULL
an	NULL
Inducible	NULL
,	NULL
T-Cell-Specific	NULL
Factor	NULL
and	NULL
an	NULL
Octamer	NULL
Binding	NULL
Protein	NULL
By	NULL
Kimberly	NULL
Davies	NULL
,	NULL
Elizabeth	NULL
C.	NULL
TePas	NULL
,	NULL
David	NULL
G.	NULL
Nathan	NULL
,	NULL
and	NULL
Bernard	NULL
Mathey-Prevot	NULL
Interleukin-3	NULL
(	NULL
IL-3	NULL
)	NULL
is	NULL
exclusively	NULL
expressed	NULL
by	NULL
activated	NULL
T	NULL
and	NULL
natural	NULL
killer	NULL
cells	NULL
,	NULL
a	NULL
function	NULL
that	NULL
is	NULL
tightly	NULL
controlled	NULL
both	NULL
in	NULL
a	NULL
lineage-specific	NULL
and	NULL
in	NULL
a	NULL
stimulation-dependent	NULL
manner	NULL
.	NULL

We	NULL
have	NULL
investigated	NULL
the	NULL
protein	NULL
binding	NULL
characteristics	NULL
and	NULL
functional	NULL
importance	NULL
of	NULL
the	NULL
ACT-1-acti-vating	NULL
region	NULL
of	NULL
the	NULL
IL-3	NULL
promoter	NULL
.	NULL

This	NULL
region	NULL
binds	NULL
an	NULL
inducible	NULL
,	NULL
T-cell-specific	NULL
factor	NULL
over	NULL
its	NULL
5	NULL
end	NULL
,	NULL
a	NULL
site	NULL
that	NULL
is	NULL
necessary	NULL
for	NULL
the	NULL
expression	NULL
of	NULL
IL-3	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
other	NULL
upstream	NULL
elements	NULL
.	NULL

Over	NULL
its	NULL
3	NULL
'	NULL
end	NULL
,	NULL
it	NULL
binds	NULL
a	NULL
factor	NULL
that	NULL
is	NULL
ubiquitously	NULL
and	NULL
constitutively	NULL
expressed	NULL
.	NULL

This	NULL
factor	NULL
NTERLEUKIN-3	NULL
(	NULL
IL-3	NULL
)	NULL
is	NULL
a	NULL
hematopoietic	NULL
growth	NULL
factor	NULL
that	NULL
supports	NULL
the	NULL
differentiation	NULL
and	NULL
proliferation	NULL
of	NULL
early	NULL
precursors	NULL
of	NULL
the	NULL
myeloid	NULL
,	NULL
erythroid	NULL
,	NULL
monocytic	NULL
,	NULL
and	NULL
mega-karyocytic	NULL
cell	NULL
lines	NULL
.	NULL
``	NULL

Its	NULL
expression	NULL
is	NULL
tightly	NULL
regulated	NULL
in	NULL
both	NULL
a	NULL
lineage-specific	NULL
and	NULL
a	NULL
stimulation-dependent	NULL
manner	NULL
and	NULL
is	NULL
restricted	NULL
to	NULL
activated	NULL
T	NULL
and	NULL
natural	NULL
killer	NULL
(	NULL
NK	NULL
)	NULL
cells	NULL
.	NULL
``	NULL

Regulation	NULL
of	NULL
IL-3	NULL
expression	NULL
takes	NULL
place	NULL
at	NULL
several	NULL
levels	NULL
,	NULL
but	NULL
it	NULL
has	NULL
been	NULL
shown	NULL
that	NULL
the	NULL
accelerated	NULL
production	NULL
of	NULL
IL-3	NULL
by	NULL
activated	NULL
T	NULL
cells	NULL
is	NULL
partly	NULL
due	NULL
to	NULL
an	NULL
increase	NULL
in	NULL
the	NULL
rate	NULL
of	NULL
transcription	NULL
of	NULL
the	NULL
gene	NULL
at	NULL
the	NULL
level	NULL
of	NULL
the	NULL
promoter	NULL
.	NULL

Therefore	NULL
,	NULL
we	NULL
have	NULL
endeavored	NULL
to	NULL
uncover	NULL
the	NULL
mechanisms	NULL
of	NULL
transcriptional	NULL
control	NULL
of	NULL
the	NULL
human	NULL
IL-3	NULL
gene	NULL
so	NULL
that	NULL
we	NULL
may	NULL
broaden	NULL
our	NULL
understanding	NULL
of	NULL
the	NULL
means	NULL
by	NULL
which	NULL
IL-3	NULL
production	NULL
is	NULL
enhanced	NULL
when	NULL
a	NULL
rapid	NULL
hematopoietic	NULL
response	NULL
is	NULL
required	NULL
.	NULL

IL-2	NULL
is	NULL
functionally	NULL
distinct	NULL
,	NULL
but	NULL
,	NULL
like	NULL
IL-3	NULL
,	NULL
its	NULL
expression	NULL
is	NULL
limited	NULL
to	NULL
activated	NULL
T	NULL
cells	NULL
.	NULL
``	NULL

The	NULL
parallel	NULL
in	NULL
expression	NULL
profiles	NULL
suggests	NULL
that	NULL
the	NULL
promoters	NULL
for	NULL
IL-2	NULL
and	NULL
IL-3	NULL
might	NULL
share	NULL
common	NULL
regulatory	NULL
elements	NULL
,	NULL
despite	NULL
the	NULL
failure	NULL
to	NULL
detect	NULL
such	NULL
elements	NULL
based	NULL
on	NULL
sequence	NULL
homology	NULL
.	NULL

Earlier	NULL
studies	NULL
have	NULL
identified	NULL
three	NULL
cis-acting	NULL
regulatory	NULL
elements	NULL
in	NULL
the	NULL
IL-3	NULL
promoter	NULL
,	NULL
all	NULL
within	NULL
300	NULL
bp	NULL
upstream	NULL
of	NULL
the	NULL
transcription	NULL
start	NULL
site	NULL
.	NULL

An	NULL
AP-1	NULL
site	NULL
at	NULL
position	NULL
-301	NULL
is	NULL
necessary	NULL
for	NULL
maximal	NULL
transcriptional	NULL
activation	NULL
.	NULL

Immediately	NULL
downstream	NULL
of	NULL
the	NULL
AP-1	NULL
site	NULL
is	NULL
a	NULL
strong	NULL
repressor	NULL
element	NULL
,	NULL
termed	NULL
NIP	NULL
,	NULL
that	NULL
completely	NULL
inhibits	NULL
gene	NULL
transcription	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
the	NULL
AP-1	NULL
site	NULL
.	NULL

A	NULL
third	NULL
regulatory	NULL
element	NULL
,	NULL
at	NULL
position	NULL
-157	NULL
,	NULL
referred	NULL
to	NULL
as	NULL
ACT-1°	NULL
or	NULL
NF-IL3-A	NULL
,	NULL
``	NULL
is	NULL
thought	NULL
to	NULL
mediate	NULL
T-cell-specific	NULL
expression	NULL
and	NULL
to	NULL
be	NULL
a	NULL
site	NULL
of	NULL
nuclear	NULL
factor	NULL
binding.©	NULL
``	NULL
We	NULL
demonstrate	NULL
here	NULL
that	NULL
this	NULL
element	NULL
actually	NULL
encompasses	NULL
two	NULL
distinct	NULL
protein-binding	NULL
sites	NULL
.	NULL

Over	NULL
its	NULL
5	NULL
'	NULL
From	NULL
the	NULL
Department	NULL
of	NULL
Pediatric	NULL
Oncology	NULL
,	NULL
Dana-Farber	NULL
Cancer	NULL
Institute	NULL
;	NULL
and	NULL
the	NULL
Department	NULL
of	NULL
Medicine	NULL
,	NULL
Children	NULL
's	NULL
Hospital	NULL
,	NULL
Bos-ton	NULL
,	NULL
MA	NULL
.	NULL

Submitted	NULL
July	NULL
13	NULL
,	NULL
1992	NULL
;	NULL
accepted	NULL
October	NULL
15	NULL
,	NULL
1992	NULL
.	NULL

Supported	NULL
by	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
(	NULL
NIH	NULL
)	NULL
Grant	NULL
No	NULL
.	NULL

ROI	NULL
DK41758	NULL
.	NULL

KD	NULL
.	NULL

was	NULL
a	NULL
recipient	NULL
of	NULL
an	NULL
NIH	NULL
grant	NULL
for	NULL
Graduate	NULL
Training	NULL
in	NULL
Cancer	NULL
Research	NULL
(	NULL
Grant	NULL
No	NULL
.	NULL

5T32CA09172-17	NULL
)	NULL
.	NULL

Address	NULL
reprint	NULL
requests	NULL
to	NULL
Bernard	NULL
Mathey-Prevot	NULL
,	NULL
PhD	NULL
,	NULL
Dana-Farber	NULL
Cancer	NULL
Institute	NULL
,	NULL
D16304	NULL
,	NULL
44	NULL
Binney	NULL
St	NULL
,	NULL
Boston	NULL
MA	NULL
02115	NULL
.	NULL

The	NULL
publication	NULL
costs	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
page	NULL
charge	NULL
payment	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
``	NULL
advertisement	NULL
``	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

section	NULL
1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

©	NULL
1993	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
.	NULL

0006-497	NULL
928	NULL
is	NULL
Oct-1	NULL
or	NULL
an	NULL
immunologically	NULL
related	NULL
octamer-binding	NULL
protein	NULL
,	NULL
and	NULL
it	NULL
plays	NULL
a	NULL
role	NULL
in	NULL
coordinating	NULL
the	NULL
activity	NULL
of	NULL
several	NULL
regulatory	NULL
elements	NULL
.	NULL

These	NULL
characteristics	NULL
make	NULL
the	NULL
ACT-1	NULL
site	NULL
analogous	NULL
to	NULL
the	NULL
activating	NULL
ARRE-1	NULL
site	NULL
in	NULL
the	NULL
IL-2	NULL
promoter	NULL
.	NULL

Furthermore	NULL
,	NULL
and	NULL
despite	NULL
a	NULL
lack	NULL
of	NULL
sequence	NULL
homology	NULL
,	NULL
the	NULL
promoters	NULL
of	NULL
IL-3	NULL
and	NULL
IL-2	NULL
share	NULL
an	NULL
organizational	NULL
pattern	NULL
of	NULL
regulatory	NULL
elements	NULL
that	NULL
is	NULL
likely	NULL
to	NULL
be	NULL
important	NULL
for	NULL
the	NULL
T-cell-specific	NULL
expression	NULL
of	NULL
these	NULL
genes	NULL
.	NULL

©	NULL
1993	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
.	NULL

end	NULL
,	NULL
ACT-1	NULL
binds	NULL
an	NULL
inducible	NULL
,	NULL
T-cell-specific	NULL
factor	NULL
that	NULL
shares	NULL
functional	NULL
properties	NULL
and	NULL
DNA-binding	NULL
affinity	NULL
with	NULL
the	NULL
Octamer-l-associated	NULL
protein	NULL
(	NULL
OAP	NULL
)	NULL
of	NULL
the	NULL
ARRE-1	NULL
element	NULL
of	NULL
the	NULL
IL-2	NULL
promoter	NULL
.	NULL

Over	NULL
its	NULL
3	NULL
end	NULL
,	NULL
ACT	NULL
-1	NULL
binds	NULL
a	NULL
constitutive	NULL
factor	NULL
that	NULL
we	NULL
show	NULL
to	NULL
be	NULL
an	NULL
octamer-binding	NULL
protein	NULL
.	NULL

Functionally	NULL
,	NULL
the	NULL
inducible	NULL
binding	NULL
factor	NULL
is	NULL
capable	NULL
of	NULL
conferring	NULL
inducible	NULL
expression	NULL
on	NULL
an	NULL
IL-3	NULL
reporter	NULL
gene	NULL
.	NULL

Although	NULL
the	NULL
constitutive	NULL
(	NULL
octamer-binding	NULL
)	NULL
factor	NULL
can	NULL
itself	NULL
lead	NULL
to	NULL
some	NULL
expression	NULL
of	NULL
a	NULL
reporter	NULL
gene	NULL
,	NULL
its	NULL
role	NULL
is	NULL
more	NULL
likely	NULL
to	NULL
coordinate	NULL
the	NULL
functions	NULL
of	NULL
the	NULL
several	NULL
cis-acting	NULL
regulatory	NULL
elements	NULL
of	NULL
the	NULL
promoter	NULL
,	NULL
leading	NULL
to	NULL
maximal	NULL
IL-3	NULL
production	NULL
upon	NULL
induction	NULL
.	NULL

Thus	NULL
,	NULL
both	NULL
the	NULL
binding	NULL
and	NULL
functional	NULL
characteristics	NULL
of	NULL
ACT-1	NULL
overlap	NULL
those	NULL
of	NULL
the	NULL
ARRE-1	NULL
site	NULL
of	NULL
the	NULL
IL-2	NULL
promoter	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Cell	NULL
culture	NULL
and	NULL
stimulation	NULL
.	NULL

-	NULL
MLA144	NULL
,	NULL
Jurkat	NULL
,	NULL
Raji	NULL
,	NULL
K562	NULL
,	NULL
U937	NULL
,	NULL
and	NULL
human	NULL
fibroblast	NULL
cell	NULL
lines	NULL
were	NULL
grown	NULL
at	NULL
37°C	NULL
,	NULL
5	NULL
%	NULL
CO	NULL
;	NULL
in	NULL
RPMI	NULL
1640	NULL
,	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
fetal	NULL
calf	NULL
serum	NULL
,	NULL
50	NULL
U/mL	NULL
penicillin	NULL
,	NULL
50	NULL
ug/mL	NULL
streptomycin	NULL
,	NULL
and	NULL
2	NULL
mmol/L	NULL
L-glutamine	NULL
.	NULL

Activation	NULL
of	NULL
MLA144	NULL
cells	NULL
was	NULL
accomplished	NULL
by	NULL
treatment	NULL
with	NULL
10	NULL
ng/mL	NULL
of	NULL
phorbol	NULL
12-myristate	NULL
13-acetate	NULL
(	NULL
PMA	NULL
)	NULL
.	NULL

Other	NULL
cell	NULL
lines	NULL
were	NULL
activated	NULL
with	NULL
both	NULL
PMA	NULL
(	NULL
10	NULL
ng/mL	NULL
)	NULL
and	NULL
ionomycin	NULL
(	NULL
0.5	NULL
amol/L	NULL
)	NULL
.	NULL

MLA	NULL
144	NULL
and	NULL
Jurkat	NULL
cells	NULL
express	NULL
IL-3	NULL
upon	NULL
activation	NULL
.	NULL
``	NULL

DNA-binding	NULL
assays	NULL
.	NULL

-	NULL
Nuclear	NULL
salt-wash	NULL
extracts	NULL
were	NULL
prepared	NULL
according	NULL
to	NULL
Dignam	NULL
et	NULL
al	NULL
.	NULL
``	NULL

Electrophoretic	NULL
mobility	NULL
shift	NULL
assays	NULL
were	NULL
performed	NULL
in	NULL
15	NULL
LL	NULL
reactions	NULL
containing	NULL
~5.7	NULL
ug	NULL
of	NULL
crude	NULL
nuclear	NULL
extract	NULL
,	NULL
1	NULL
to	NULL
3	NULL
ug	NULL
of	NULL
poly	NULL
dI-dC	NULL
,	NULL
and	NULL
buffer	NULL
(	NULL
10	NULL
mmol/L	NULL
HEPES	NULL
,	NULL
pH	NULL
7.8/5	NULL
mmol/L	NULL
potassium	NULL
glutamate/5	NULL
mmol/L	NULL
MgCl	NULL
;	NULL
/	NULL
!	NULL

1	NULL
mmol/L	NULL
EDTA/1	NULL
mmol/L	NULL
dithiothreitol/5	NULL
%	NULL
[	NULL
vol/vol	NULL
]	NULL
glycerol	NULL
)	NULL
.	NULL

The	NULL
binding	NULL
activity	NULL
of	NULL
the	NULL
inducible	NULL
factor	NULL
was	NULL
noted	NULL
to	NULL
be	NULL
sensitive	NULL
to	NULL
changes	NULL
in	NULL
the	NULL
poly	NULL
dI-dC	NULL
stock	NULL
.	NULL

For	NULL
competition	NULL
experiments	NULL
,	NULL
excess	NULL
unlabeled	NULL
oligonucleotide	NULL
competitors	NULL
(	NULL
40	NULL
to	NULL
80	NULL
ng	NULL
)	NULL
were	NULL
preincubated	NULL
with	NULL
the	NULL
nuclear	NULL
extract	NULL
at	NULL
0°C	NULL
for	NULL
8	NULL
minutes	NULL
before	NULL
addition	NULL
of	NULL
P-labeled	NULL
probe	NULL
.	NULL

The	NULL
reaction	NULL
was	NULL
then	NULL
further	NULL
incubated	NULL
at	NULL
0°C	NULL
for	NULL
30	NULL
minutes	NULL
before	NULL
the	NULL
DNA-protein	NULL
complexes	NULL
were	NULL
separated	NULL
on	NULL
a	NULL
nondenaturing	NULL
acrylamide	NULL
gel	NULL
(	NULL
4	NULL
%	NULL
to	NULL
6.5	NULL
%	NULL
)	NULL
at	NULL
180	NULL
V	NULL
for	NULL
2.5	NULL
hours	NULL
.	NULL

Gels	NULL
were	NULL
dried	NULL
before	NULL
autoradiography	NULL
.	NULL

Oligonucleotide	NULL
competitors	NULL
were	NULL
synthetically	NULL
generated	NULL
.	NULL

Supershift	NULL
assay	NULL
and	NULL
methylation	NULL
interference	NULL
.	NULL

-	NULL
The	NULL
mobility	NULL
shift	NULL
reaction	NULL
was	NULL
incubated	NULL
at	NULL
0°C	NULL
with	NULL
the	NULL
probe	NULL
for	NULL
30	NULL
minutes	NULL
before	NULL
the	NULL
addition	NULL
of	NULL
0.15	NULL
LL	NULL
of	NULL
antiserum	NULL
.	NULL

The	NULL
reaction	NULL
was	NULL
then	NULL
incubated	NULL
at	NULL
0°C	NULL
for	NULL
another	NULL
30	NULL
minutes	NULL
.	NULL

Alternatively	NULL
,	NULL
0.15	NULL
L	NULL
of	NULL
antiserum	NULL
was	NULL
incubated	NULL
at	NULL
0°C	NULL
for	NULL
30	NULL
minutes	NULL
before	NULL
addition	NULL
of	NULL
the	NULL
probe	NULL
.	NULL

Antiserum	NULL
was	NULL
provided	NULL
by	NULL
Gerald	NULL
R.	NULL
Crabtree	NULL
(	NULL
Stanford	NULL
University	NULL
,	NULL
Stanford	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

It	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
bind	NULL
Oct-1	NULL
,	NULL
but	NULL
has	NULL
not	NULL
been	NULL
tested	NULL
for	NULL
cross-reactivity	NULL
with	NULL
Oct-2	NULL
.	NULL

Methylation	NULL
interference	NULL
experiments	NULL
were	NULL
performed	NULL
as	NULL
described	NULL
by	NULL
Martin	NULL
et	NULL
al	NULL
.	NULL
'	NULL

''	NULL
Blood	NULL
,	NULL
Vol	NULL
81	NULL
,	NULL
No	NULL
4	NULL
(	NULL
February	NULL
15	NULL
)	NULL
,	NULL
1993	NULL
:	NULL
pp	NULL
928-934	NULL
From	NULL
www	NULL
.	NULL

bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

ROLE	NULL
OF	NULL
THE	NULL
ACT-1	NULL
SITE	NULL
IN	NULL
IL-3	NULL
EXPRESSION	NULL
IL-3	NULL
reporter	NULL
genes	NULL
.	NULL

-	NULL
The	NULL
reporter	NULL
gene	NULL
constructs	NULL
consist	NULL
of	NULL
human	NULL
genomic	NULL
IL-3	NULL
sequences	NULL
that	NULL
include	NULL
various	NULL
lengths	NULL
of	NULL
upstream	NULL
promoter	NULL
sequences	NULL
and	NULL
that	NULL
extend	NULL
to	NULL
the	NULL
EcoRI	NULL
site	NULL
downstream	NULL
of	NULL
the	NULL
last	NULL
exon	NULL
.	NULL

The	NULL
first	NULL
exon	NULL
contains	NULL
a	NULL
12-mer	NULL
X/o	NULL
I	NULL
linker	NULL
insertion	NULL
at	NULL
a	NULL
unique	NULL
Hpa	NULL
I	NULL
site	NULL
,	NULL
as	NULL
previously	NULL
The	NULL
Stu	NULL
I	NULL
site	NULL
at	NULL
-315	NULL
and	NULL
the	NULL
Sca	NULL
I	NULL
site	NULL
at	NULL
-173	NULL
were	NULL
used	NULL
to	NULL
generate	NULL
the	NULL
-315	NULL
and	NULL
-173	NULL
constructs	NULL
,	NULL
respectively	NULL
.	NULL

Internal	NULL
mutations	NULL
within	NULL
the	NULL
-315	NULL
promoter	NULL
were	NULL
made	NULL
by	NULL
polymerase	NULL
chain	NULL
reactions	NULL
(	NULL
PCRs	NULL
)	NULL
.	NULL

To	NULL
generate	NULL
the	NULL
construct	NULL
with	NULL
a	NULL
mutated	NULL
constitutive	NULL
binding	NULL
site	NULL
,	NULL
the	NULL
sequences	NULL
from	NULL
-315	NULL
to	NULL
-147	NULL
(	NULL
primers	NULL
A	NULL
and	NULL
B	NULL
)	NULL
and	NULL
from	NULL
-138	NULL
to	NULL
the	NULL
CAP	NULL
site	NULL
(	NULL
primers	NULL
C	NULL
and	NULL
D	NULL
)	NULL
were	NULL
each	NULL
amplified	NULL
using	NULL
the	NULL
following	NULL
primers	NULL
.	NULL

Primer	NULL
A	NULL
includes	NULL
the	NULL
#	NULL
find3-containing	NULL
polylinker	NULL
sequence	NULL
upstream	NULL
of	NULL
-315	NULL
(	NULL
CATGATTACGCCAAGCTTGGG	NULL
)	NULL
.	NULL

Primer	NULL
B	NULL
inserts	NULL
a	NULL
BamHI	NULL
site	NULL
downstream	NULL
of	NULL
-147	NULL
(	NULL
GGGGG-ATCCTTATTCATCCATGACTT	NULL
)	NULL
.	NULL

Primer	NULL
C	NULL
inserts	NULL
a	NULL
BamHI	NULL
site	NULL
upstream	NULL
of	NULL
-138	NULL
(	NULL
GGGGGATCCGTGGTTTTCTATGGAGG	NULL
)	NULL
.	NULL

Primer	NULL
D	NULL
includes	NULL
the	NULL
CAP	NULL
site	NULL
(	NULL
AAAGGATCCTGAAGAGT-TGGCAAC	NULL
)	NULL
.	NULL

The	NULL
two	NULL
PCR	NULL
fragments	NULL
were	NULL
ligated	NULL
at	NULL
their	NULL
BamHI	NULL
sites	NULL
.	NULL

The	NULL
ligated	NULL
fragment	NULL
was	NULL
digested	NULL
with	NULL
Hind3	NULL
and	NULL
Sma	NULL
I	NULL
(	NULL
site	NULL
at	NULL
position	NULL
-61	NULL
)	NULL
and	NULL
was	NULL
then	NULL
subcloned	NULL
into	NULL
the	NULL
reporter	NULL
gene	NULL
construct	NULL
between	NULL
the	NULL
#	NULL
7ind3	NULL
site	NULL
in	NULL
the	NULL
pUC	NULL
13	NULL
polylinker	NULL
and	NULL
the	NULL
Sma	NULL
I	NULL
site	NULL
at	NULL
-61	NULL
.	NULL

To	NULL
generate	NULL
the	NULL
construct	NULL
with	NULL
the	NULL
entire	NULL
ACT-1	NULL
site	NULL
mutated	NULL
,	NULL
the	NULL
sequences	NULL
from	NULL
-315	NULL
to	NULL
-155	NULL
(	NULL
primers	NULL
A	NULL
and	NULL
E	NULL
)	NULL
and	NULL
from	NULL
-138	NULL
to	NULL
the	NULL
CAP	NULL
site	NULL
(	NULL
primers	NULL
C	NULL
and	NULL
D	NULL
)	NULL
were	NULL
each	NULL
amplified	NULL
.	NULL

Primer	NULL
E	NULL
inserts	NULL
a	NULL
BamHI	NULL
site	NULL
downstream	NULL
of	NULL
-155	NULL
(	NULL
GGGGGATCCCCATGACTTTCTAGTAC	NULL
)	NULL
.	NULL

These	NULL
PCR	NULL
fragments	NULL
were	NULL
ligated	NULL
and	NULL
subcloned	NULL
as	NULL
above	NULL
.	NULL

The	NULL
corresponding	NULL
-173	NULL
constructs	NULL
were	NULL
made	NULL
by	NULL
Sca	NULL
I	NULL
digestion	NULL
of	NULL
the	NULL
mutated	NULL
-31	NULL
5	NULL
constructs	NULL
.	NULL

Sequence	NULL
analysis	NULL
of	NULL
these	NULL
constructs	NULL
confirmed	NULL
the	NULL
accuracy	NULL
of	NULL
the	NULL
mutations	NULL
.	NULL

Electroporation	NULL
and	NULL
RNA	NULL
isolation	NULL
.	NULL

-	NULL
Reporter	NULL
genes	NULL
were	NULL
introduced	NULL
into	NULL
MLA144	NULL
cells	NULL
by	NULL
electroporation	NULL
.	NULL

Cells	NULL
(	NULL
3	NULL
X	NULL
10	NULL
``	NULL
)	NULL
were	NULL
pelleted	NULL
and	NULL
resuspended	NULL
in	NULL
2.4	NULL
mL	NULL
of	NULL
serum-free	NULL
RPMI	NULL
.	NULL

Fifty	NULL
micrograms	NULL
of	NULL
reporter	NULL
gene	NULL
DNA	NULL
in	NULL
a	NULL
pUC	NULL
13	NULL
vector	NULL
was	NULL
added	NULL
to	NULL
the	NULL
cells	NULL
.	NULL

After	NULL
incubation	NULL
on	NULL
ice	NULL
for	NULL
5	NULL
minutes	NULL
,	NULL
the	NULL
DNA	NULL
was	NULL
elec-troporated	NULL
into	NULL
the	NULL
cells	NULL
in	NULL
0.8-mL	NULL
aliquots	NULL
at	NULL
275	NULL
V	NULL
and	NULL
980	NULL
LF	NULL
.	NULL

Cells	NULL
were	NULL
resuspended	NULL
in	NULL
55	NULL
mL	NULL
of	NULL
RPMI	NULL
complete	NULL
and	NULL
incubated	NULL
at	NULL
37°C	NULL
.	NULL

At	NULL
36	NULL
hours	NULL
,	NULL
cells	NULL
were	NULL
stimulated	NULL
with	NULL
PMA	NULL
and	NULL
9	NULL
hours	NULL
later	NULL
,	NULL
they	NULL
were	NULL
lysed	NULL
with	NULL
guanidium	NULL
isothiocyanate	NULL
(	NULL
GITC	NULL
)	NULL
and	NULL
RNA	NULL
was	NULL
isolated	NULL
,	NULL
as	NULL
described	NULL
by	NULL
Niemeyer	NULL
et	NULL
al	NULL
.	NULL

RNase	NULL
protection	NULL
assay	NULL
.	NULL

-	NULL
Twenty-five	NULL
micrograms	NULL
of	NULL
total	NULL
cellular	NULL
RNA	NULL
was	NULL
resuspended	NULL
in	NULL
31	NULL
LL	NULL
of	NULL
hyb-buffer	NULL
(	NULL
80	NULL
%	NULL
[	NULL
vol/vol	NULL
]	NULL
forma-mide/40	NULL
mmol/L	NULL
PIPES	NULL
,	NULL
pH	NULL
6.4/400	NULL
mmol/L	NULL
NaCl/1	NULL
mmol/L	NULL
EDTA	NULL
)	NULL
containing	NULL
the	NULL
appropriate	NULL
``	NULL
P-labeled	NULL
RNA	NULL
probe	NULL
.	NULL

RNase	NULL
protection	NULL
was	NULL
as	NULL
previously	NULL
described.©	NULL
Hybridization	NULL
was	NULL
performed	NULL
at	NULL
52°C	NULL
overnight	NULL
.	NULL

Digestion	NULL
with	NULL
RNase	NULL
A	NULL
and	NULL
TI	NULL
was	NULL
performed	NULL
at	NULL
37°C	NULL
for	NULL
30	NULL
minutes	NULL
.	NULL

Reactions	NULL
were	NULL
treated	NULL
with	NULL
proteinase	NULL
K	NULL
at	NULL
37°C	NULL
for	NULL
30	NULL
minutes	NULL
,	NULL
extracted	NULL
with	NULL
phenol/chloroform	NULL
,	NULL
and	NULL
loaded	NULL
on	NULL
a	NULL
6	NULL
%	NULL
Tris	NULL
borate	NULL
EDTA	NULL
(	NULL
TBE	NULL
)	NULL
acrylamide/urea	NULL
gel	NULL
.	NULL

For	NULL
the	NULL
probe	NULL
,	NULL
a	NULL
Sma	NULL
I-Pst	NULL
I	NULL
fragment	NULL
containing	NULL
exon	NULL
1	NULL
of	NULL
the	NULL
IL-3	NULL
gene	NULL
was	NULL
modified	NULL
by	NULL
insertion	NULL
of	NULL
a	NULL
Xho	NULL
I	NULL
linker	NULL
(	NULL
12-mer	NULL
)	NULL
at	NULL
a	NULL
unique	NULL
Z7pa	NULL
I	NULL
site	NULL
and	NULL
subcloned	NULL
into	NULL
SPT	NULL
18	NULL
(	NULL
Boehringer	NULL
Mannheim	NULL
,	NULL
Indianapolis	NULL
,	NULL
IN	NULL
)	NULL
.	NULL

The	NULL
antisense	NULL
probe	NULL
(	NULL
330	NULL
nt	NULL
)	NULL
is	NULL
obtained	NULL
with	NULL
SP6	NULL
polymerase	NULL
after	NULL
linearization	NULL
with	NULL
EcoRI	NULL
,	NULL
as	NULL
previously	NULL
described	NULL
by	NULL
Mathey-Prevot	NULL
et	NULL
al	NULL
.	NULL

On	NULL
RNase	NULL
protection	NULL
assay	NULL
,	NULL
the	NULL
reporter	NULL
gene	NULL
yields	NULL
a	NULL
226-bp	NULL
protected	NULL
fragment	NULL
,	NULL
whereas	NULL
the	NULL
endogenous	NULL
gibbon	NULL
IL-3	NULL
messenger	NULL
RNA	NULL
(	NULL
mRNA	NULL
)	NULL
yields	NULL
two	NULL
protected	NULL
fragments	NULL
of	NULL
151	NULL
and	NULL
63	NULL
nt	NULL
.	NULL

RESULTS	NULL
Binding	NULL
assays	NULL
.	NULL

-	NULL
To	NULL
examine	NULL
the	NULL
nuclear	NULL
factor	NULL
binding	NULL
characteristics	NULL
of	NULL
the	NULL
ACT-1	NULL
promoter	NULL
element	NULL
,	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assays	NULL
were	NULL
performed	NULL
with	NULL
nuclear	NULL
extracts	NULL
prepared	NULL
from	NULL
MLA	NULL
144	NULL
cells	NULL
,	NULL
a	NULL
gibbon	NULL
T-cell	NULL
leukemia	NULL
929	NULL
©1990	NULL
whee	NULL
138	NULL
CATGGATGAATAATTACGTCTG	NULL
GTACCTACTTATTAATGCAGAC	NULL
o	NULL
ee	NULL
all	NULL
Fig	NULL
1	NULL
.	NULL

-	NULL
The	NULL
ACT-1	NULL
probe	NULL
(	NULL
CATGGATGAATAATTACGTCTG	NULL
)	NULL
binds	NULL
a	NULL
constitutive	NULL
and	NULL
inducible	NULL
factor	NULL
.	NULL

Constitutive	NULL
(	NULL
solid	NULL
arrow	NULL
)	NULL
and	NULL
inducible	NULL
bindings	NULL
(	NULL
open	NULL
arrow	NULL
)	NULL
are	NULL
indicated	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Lane	NULL
a	NULL
,	NULL
unstimulated	NULL
MLA	NULL
144	NULL
nuclear	NULL
extracts	NULL
.	NULL

Lanes	NULL
b	NULL
and	NULL
c	NULL
,	NULL
stimulated	NULL
MLA	NULL
144	NULL
nuclear	NULL
extracts	NULL
.	NULL

Lanes	NULL
a	NULL
and	NULL
b	NULL
,	NULL
no	NULL
competitor	NULL
.	NULL

Lane	NULL
c	NULL
,	NULL
ACT-1	NULL
(	NULL
-159	NULL
,	NULL
-138	NULL
)	NULL
competitor	NULL
.	NULL

(	NULL
B	NULL
)	NULL
ACT-1	NULL
probe	NULL
.	NULL

Methylation	NULL
interference	NULL
deduced	NULL
DNA-protein	NULL
contacts	NULL
with	NULL
this	NULL
probe	NULL
and	NULL
the	NULL
constitutive	NULL
complex	NULL
(	NULL
+	NULL
)	NULL
are	NULL
indicated	NULL
.	NULL

DNA	NULL
protein	NULL
contacts	NULL
with	NULL
the	NULL
inducible	NULL
complex	NULL
and	NULL
the	NULL
5	NULL
'	NULL
probe	NULL
(	NULL
-159	NULL
,	NULL
147	NULL
)	NULL
(	NULL
see	NULL
D	NULL
)	NULL
are	NULL
indicated	NULL
(	NULL
x	NULL
)	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Lanes	NULL
a	NULL
and	NULL
b	NULL
,	NULL
stimulated	NULL
MLA	NULL
144	NULL
.	NULL

Lane	NULL
a	NULL
,	NULL
3	NULL
'	NULL
(	NULL
-151	NULL
,	NULL
-142	NULL
)	NULL
competitor	NULL
;	NULL
lane	NULL
b	NULL
,	NULL
5¢	NULL
(	NULL
-159	NULL
,	NULL
-147	NULL
)	NULL
competitor	NULL
.	NULL

(	NULL
D	NULL
)	NULL
Gel	NULL
shift	NULL
performed	NULL
with	NULL
the	NULL
5	NULL
probe	NULL
CATGGATGAATAA	NULL
(	NULL
lanes	NULL
a	NULL
through	NULL
c	NULL
)	NULL
,	NULL
the	NULL
ACT-1	NULL
probe	NULL
(	NULL
-159	NULL
,	NULL
-138	NULL
)	NULL
(	NULL
lanes	NULL
d	NULL
through	NULL
e	NULL
}	NULL
)	NULL
,	NULL
and	NULL
the	NULL
3	NULL
'	NULL
probe	NULL
AATAATTACG	NULL
(	NULL
lanes	NULL
f	NULL
through	NULL
h	NULL
)	NULL
.	NULL

Lanes	NULL
a	NULL
and	NULL
f	NULL
,	NULL
unstimulated	NULL
MLA	NULL
144	NULL
nuclear	NULL
extracts	NULL
.	NULL

Lanes	NULL
b	NULL
through	NULL
e	NULL
,	NULL
g	NULL
,	NULL
and	NULL
h	NULL
,	NULL
stimulated	NULL
MLA144	NULL
nuclear	NULL
extracts	NULL
.	NULL

Lanes	NULL
a	NULL
,	NULL
b	NULL
,	NULL
f	NULL
,	NULL
and	NULL
g	NULL
,	NULL
no	NULL
competitor	NULL
;	NULL
lane	NULL
c	NULL
,	NULL
5¢	NULL
(	NULL
-159	NULL
,	NULL
-147	NULL
)	NULL
competitor	NULL
;	NULL
lane	NULL
e	NULL
,	NULL
ACT-1	NULL
(	NULL
-159	NULL
,	NULL
-138	NULL
)	NULL
competitor	NULL
;	NULL
lane	NULL
h	NULL
,	NULL
3	NULL
(	NULL
-151	NULL
,	NULL
-142	NULL
)	NULL
competitor	NULL
.	NULL

line	NULL
.	NULL
``	NULL

Figure	NULL
1A	NULL
shows	NULL
the	NULL
gel-retardation	NULL
pattern	NULL
obtained	NULL
when	NULL
a	NULL
radioactively	NULL
labeled	NULL
probe	NULL
of	NULL
the	NULL
entire	NULL
ACT-1	NULL
sequence	NULL
(	NULL
Fig	NULL
1B	NULL
)	NULL
is	NULL
treated	NULL
with	NULL
equal	NULL
amounts	NULL
of	NULL
nuclear	NULL
extract	NULL
from	NULL
unstimulated	NULL
or	NULL
PMA-stimulated	NULL
cells	NULL
.	NULL

There	NULL
are	NULL
two	NULL
distinct	NULL
patterns	NULL
of	NULL
binding	NULL
over	NULL
this	NULL
22	NULL
nucleotide	NULL
region	NULL
of	NULL
the	NULL
promoter	NULL
:	NULL
one	NULL
factor	NULL
binds	NULL
constitutively	NULL
and	NULL
the	NULL
other	NULL
inducibly	NULL
.	NULL

The	NULL
top	NULL
band	NULL
is	NULL
the	NULL
predominant	NULL
complex	NULL
and	NULL
is	NULL
apparent	NULL
with	NULL
unstimulated	NULL
nuclear	NULL
extract	NULL
(	NULL
lane	NULL
a	NULL
)	NULL
.	NULL

It	NULL
remains	NULL
present	NULL
and	NULL
of	NULL
equal	NULL
intensity	NULL
with	NULL
stimulated	NULL
nuclear	NULL
extract	NULL
(	NULL
lane	NULL
b	NULL
)	NULL
.	NULL

A	NULL
second	NULL
band	NULL
,	NULL
of	NULL
lesser	NULL
intensity	NULL
and	NULL
migrating	NULL
slightly	NULL
ahead	NULL
of	NULL
the	NULL
constitutive	NULL
complex	NULL
,	NULL
is	NULL
From	NULL
www	NULL
.	NULL

bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

930	NULL
DAVIES	NULL
ET	NULL
AL	NULL
Fig	NULL
2	NULL
.	NULL

The	NULL
5	NULL
region	NULL
of	NULL
ACT-1	NULL
binds	NULL
an	NULL
inducible	NULL
,	NULL
T-cell-specific	NULL
factor	NULL
.	NULL

Gel	NULL
shift	NULL
assays	NULL
were	NULL
performed	NULL
with	NULL
the	NULL
5¢	NULL
probe	NULL
(	NULL
-159	NULL
,	NULL
-147	NULL
)	NULL
.	NULL

Migration	NULL
of	NULL
the	NULL
inducible	NULL
complex	NULL
(	NULL
open	NULL
arrow	NULL
)	NULL
is	NULL
indicated	NULL
.	NULL

(	NULL
A	NULL
)	NULL
MLA	NULL
144	NULL
cells	NULL
were	NULL
stimulated	NULL
with	NULL
PMA	NULL
for	NULL
the	NULL
indicated	NULL
amount	NULL
of	NULL
time	NULL
before	NULL
nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
.	NULL

Lane	NULL
a	NULL
,	NULL
0	NULL
hours	NULL
;	NULL
lane	NULL
b	NULL
,	NULL
2	NULL
hours	NULL
;	NULL
lane	NULL
c	NULL
,	NULL
4	NULL
hours	NULL
;	NULL
lane	NULL
d	NULL
,	NULL
9	NULL
hours	NULL
;	NULL
and	NULL
lane	NULL
e	NULL
,	NULL
9	NULL
hours	NULL
,	NULL
with	NULL
5	NULL
'	NULL
competitor	NULL
(	NULL
-159	NULL
,	NULL
-147	NULL
)	NULL
added	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Binding	NULL
to	NULL
the	NULL
5	NULL
probe	NULL
(	NULL
-159	NULL
,	NULL
-147	NULL
)	NULL
by	NULL
nuclear	NULL
extracts	NULL
from	NULL
unstimulated	NULL
Jurkat	NULL
cells	NULL
(	NULL
lane	NULL
a	NULL
)	NULL
or	NULL
Jurkat	NULL
cells	NULL
stimulated	NULL
with	NULL
PMA	NULL
and	NULL
ionomycin	NULL
for	NULL
9	NULL
hours	NULL
(	NULL
lanes	NULL
b	NULL
and	NULL
c	NULL
)	NULL
.	NULL

Lanes	NULL
a	NULL
and	NULL
b	NULL
,	NULL
no	NULL
competitor	NULL
;	NULL
lane	NULL
c	NULL
,	NULL
5¢	NULL
probe	NULL
competitor	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Human	NULL
hematopoietic	NULL
cell	NULL
lines	NULL
were	NULL
stimulated	NULL
with	NULL
PMA	NULL
and	NULL
ionomycin	NULL
.	NULL

Lanes	NULL
a	NULL
and	NULL
b	NULL
,	NULL
Raji	NULL
cells	NULL
;	NULL
lanes	NULL
c	NULL
and	NULL
d	NULL
,	NULL
K562	NULL
cells	NULL
;	NULL
lanes	NULL
e	NULL
and	NULL
f	NULL
,	NULL
U937	NULL
;	NULL
lanes	NULL
g	NULL
and	NULL
h	NULL
,	NULL
PMA-stimulated	NULL
MLA	NULL
144	NULL
cells	NULL
.	NULL

Lanes	NULL
a	NULL
,	NULL
c	NULL
,	NULL
e	NULL
,	NULL
and	NULL
g	NULL
,	NULL
no	NULL
competitor	NULL
;	NULL
lanes	NULL
b	NULL
,	NULL
d	NULL
,	NULL
f	NULL
,	NULL
and	NULL
h	NULL
,	NULL
5	NULL
'	NULL
probe	NULL
competitor	NULL
.	NULL

absent	NULL
with	NULL
the	NULL
unstimulated	NULL
extract	NULL
but	NULL
appears	NULL
after	NULL
cell	NULL
stimulation	NULL
.	NULL

Both	NULL
bindings	NULL
are	NULL
specific	NULL
,	NULL
as	NULL
excess	NULL
unlabeled	NULL
probe	NULL
competes	NULL
with	NULL
labeled	NULL
probe	NULL
for	NULL
binding	NULL
(	NULL
lane	NULL
c	NULL
)	NULL
.	NULL

Other	NULL
bands	NULL
observed	NULL
in	NULL
Fig	NULL
1A	NULL
represent	NULL
nonspecific	NULL
binding	NULL
to	NULL
the	NULL
probe	NULL
.	NULL

To	NULL
localize	NULL
the	NULL
two	NULL
binding	NULL
sites	NULL
within	NULL
the	NULL
ACT	NULL
1	NULL
element	NULL
,	NULL
two	NULL
overlapping	NULL
oligonucleotides	NULL
that	NULL
span	NULL
either	NULL
the	NULL
3	NULL
'	NULL
(	NULL
nt	NULL
-151	NULL
through	NULL
-142	NULL
)	NULL
or	NULL
the	NULL
5	NULL
(	NULL
nt	NULL
-159	NULL
through	NULL
-147	NULL
)	NULL
end	NULL
of	NULL
ACT	NULL
-1	NULL
were	NULL
used	NULL
as	NULL
competitors	NULL
of	NULL
the	NULL
binding	NULL
to	NULL
the	NULL
ACT-1	NULL
probe	NULL
(	NULL
Fig	NULL
1C	NULL
)	NULL
.	NULL

The	NULL
constitutive	NULL
band	NULL
is	NULL
selectively	NULL
competed	NULL
by	NULL
the	NULL
3	NULL
'	NULL
oligonucleotide	NULL
(	NULL
lane	NULL
a	NULL
)	NULL
,	NULL
whereas	NULL
the	NULL
5°	NULL
oligonucleotide	NULL
specifically	NULL
competes	NULL
the	NULL
inducible	NULL
binding	NULL
(	NULL
lane	NULL
b	NULL
)	NULL
.	NULL

The	NULL
close	NULL
proximity	NULL
of	NULL
these	NULL
binding	NULL
sites	NULL
raises	NULL
the	NULL
question	NULL
of	NULL
whether	NULL
these	NULL
two	NULL
factors	NULL
can	NULL
bind	NULL
independently	NULL
of	NULL
one	NULL
another	NULL
.	NULL

To	NULL
address	NULL
this	NULL
issue	NULL
,	NULL
two	NULL
probes	NULL
corresponding	NULL
to	NULL
the	NULL
5	NULL
'	NULL
and	NULL
3	NULL
'	NULL
oligonucleotides	NULL
used	NULL
in	NULL
the	NULL
above	NULL
competition	NULL
experiment	NULL
were	NULL
compared	NULL
with	NULL
the	NULL
ACT-1	NULL
probe	NULL
for	NULL
their	NULL
ability	NULL
to	NULL
bind	NULL
nuclear	NULL
proteins	NULL
from	NULL
unstimulated	NULL
and	NULL
stimulated	NULL
MLA	NULL
144	NULL
cells	NULL
(	NULL
Fig	NULL
1D	NULL
)	NULL
.	NULL

An	NULL
inducible	NULL
factor	NULL
,	NULL
absent	NULL
in	NULL
unstimulated	NULL
extract	NULL
(	NULL
lane	NULL
a	NULL
)	NULL
,	NULL
is	NULL
seen	NULL
to	NULL
bind	NULL
to	NULL
the	NULL
5	NULL
'	NULL
probe	NULL
(	NULL
lane	NULL
b	NULL
)	NULL
and	NULL
is	NULL
specifically	NULL
competed	NULL
by	NULL
excess	NULL
unlabeled	NULL
probe	NULL
(	NULL
lane	NULL
c	NULL
)	NULL
.	NULL

The	NULL
migration	NULL
of	NULL
this	NULL
complex	NULL
is	NULL
identical	NULL
to	NULL
the	NULL
lower	NULL
,	NULL
inducible	NULL
complex	NULL
observed	NULL
with	NULL
the	NULL
ACT-1	NULL
probe	NULL
(	NULL
lane	NULL
d	NULL
)	NULL
that	NULL
is	NULL
specifically	NULL
competed	NULL
by	NULL
excess	NULL
ACT-1	NULL
probe	NULL
(	NULL
lane	NULL
e	NULL
)	NULL
.	NULL

However	NULL
,	NULL
the	NULL
3	NULL
'	NULL
probe	NULL
interacts	NULL
with	NULL
a	NULL
constitutive	NULL
factor	NULL
whose	NULL
binding	NULL
is	NULL
unaffected	NULL
by	NULL
T-cell	NULL
activation	NULL
(	NULL
lanes	NULL
f	NULL
and	NULL
g	NULL
)	NULL
.	NULL

This	NULL
complex	NULL
is	NULL
specific	NULL
as	NULL
it	NULL
is	NULL
efficiently	NULL
competed	NULL
with	NULL
excess	NULL
unlabeled	NULL
3	NULL
'	NULL
probe	NULL
(	NULL
lane	NULL
h	NULL
)	NULL
and	NULL
comigrates	NULL
with	NULL
the	NULL
constitutive	NULL
complex	NULL
observed	NULL
with	NULL
ACT-1	NULL
(	NULL
lane	NULL
d	NULL
)	NULL
.	NULL

Due	NULL
to	NULL
the	NULL
choice	NULL
of	NULL
a	NULL
lower	NULL
percentage	NULL
gel	NULL
,	NULL
the	NULL
difference	NULL
in	NULL
migration	NULL
between	NULL
the	NULL
constitutive	NULL
and	NULL
inducible	NULL
complexes	NULL
in	NULL
Fig	NULL
1D	NULL
is	NULL
better	NULL
resolved	NULL
.	NULL

Because	NULL
the	NULL
migration	NULL
for	NULL
the	NULL
constitutive	NULL
and	NULL
inducible	NULL
complexes	NULL
does	NULL
not	NULL
change	NULL
when	NULL
3	NULL
'	NULL
or	NULL
5	NULL
'	NULL
probes	NULL
,	NULL
respectively	NULL
,	NULL
are	NULL
compared	NULL
with	NULL
the	NULL
ACT-1	NULL
probe	NULL
,	NULL
it	NULL
appears	NULL
that	NULL
,	NULL
under	NULL
our	NULL
conditions	NULL
,	NULL
these	NULL
two	NULL
factors	NULL
bind	NULL
independently	NULL
of	NULL
each	NULL
other	NULL
and	NULL
may	NULL
be	NULL
mutually	NULL
ex-clusive	NULL
.	NULL

However	NULL
,	NULL
we	NULL
can	NULL
not	NULL
exclude	NULL
the	NULL
possibility	NULL
that	NULL
,	NULL
in	NULL
vivo	NULL
,	NULL
the	NULL
two	NULL
factors	NULL
bind	NULL
simultaneously	NULL
to	NULL
the	NULL
ACT-1	NULL
site	NULL
.	NULL

Methylation	NULL
interference	NULL
analysis	NULL
performed	NULL
on	NULL
the	NULL
top	NULL
band	NULL
,	NULL
using	NULL
an	NULL
ACT	NULL
-1	NULL
probe	NULL
labeled	NULL
on	NULL
the	NULL
noncoding	NULL
strand	NULL
,	NULL
shows	NULL
that	NULL
the	NULL
constitutive	NULL
binding	NULL
occurs	NULL
over	NULL
nt	NULL
-149	NULL
through	NULL
-145	NULL
.	NULL

Similar	NULL
analysis	NULL
of	NULL
the	NULL
inducible	NULL
complex	NULL
,	NULL
using	NULL
the	NULL
5	NULL
'	NULL
probe	NULL
labeled	NULL
on	NULL
the	NULL
coding	NULL
strand	NULL
,	NULL
shows	NULL
binding	NULL
over	NULL
nt	NULL
-155	NULL
through	NULL
-150	NULL
(	NULL
Fig	NULL
1B	NULL
)	NULL
.	NULL

These	NULL
data	NULL
indicate	NULL
that	NULL
,	NULL
in	NULL
vitro	NULL
,	NULL
the	NULL
two	NULL
nuclear	NULL
factors	NULL
contact	NULL
adjacent	NULL
regions	NULL
over	NULL
a	NULL
short	NULL
stretch	NULL
of	NULL
DNA	NULL
.	NULL

To	NULL
evaluate	NULL
how	NULL
soon	NULL
the	NULL
inducible	NULL
binding	NULL
can	NULL
be	NULL
observed	NULL
after	NULL
T-cell	NULL
activation	NULL
,	NULL
we	NULL
performed	NULL
a	NULL
time	NULL
course	NULL
with	NULL
nuclear	NULL
extracts	NULL
prepared	NULL
at	NULL
increasing	NULL
intervals	NULL
after	NULL
stimulation	NULL
.	NULL

Figure	NULL
2A	NULL
shows	NULL
that	NULL
there	NULL
is	NULL
progressive	NULL
binding	NULL
of	NULL
a	NULL
nuclear	NULL
factor	NULL
to	NULL
the	NULL
5	NULL
'	NULL
oligonucleotide	NULL
probe	NULL
from	NULL
0	NULL
to	NULL
9	NULL
hours	NULL
after	NULL
PMA	NULL
stimulation	NULL
.	NULL

The	NULL
binding	NULL
kinetics	NULL
over	NULL
this	NULL
site	NULL
parallel	NULL
the	NULL
time	NULL
course	NULL
analysis	NULL
observed	NULL
for	NULL
IL-3	NULL
transcription	NULL
in	NULL
MLA	NULL
144	NULL
cells	NULL
.	NULL
``	NULL

Binding	NULL
is	NULL
specific	NULL
,	NULL
as	NULL
it	NULL
can	NULL
be	NULL
competed	NULL
with	NULL
excess	NULL
unlabeled	NULL
probe	NULL
.	NULL

Other	NULL
bands	NULL
seen	NULL
in	NULL
lanes	NULL
a	NULL
through	NULL
d	NULL
represent	NULL
nonspecific	NULL
bindings	NULL
as	NULL
they	NULL
fail	NULL
to	NULL
compete	NULL
(	NULL
lane	NULL
e	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
to	NULL
its	NULL
inducibility	NULL
,	NULL
one	NULL
feature	NULL
of	NULL
the	NULL
regulation	NULL
of	NULL
IL-3	NULL
transcription	NULL
is	NULL
its	NULL
T-cell	NULL
specificity	NULL
.	NULL

To	NULL
determine	NULL
whether	NULL
the	NULL
protein	NULL
that	NULL
binds	NULL
to	NULL
the	NULL
5°	NULL
element	NULL
of	NULL
ACT-1	NULL
is	NULL
T-cell	NULL
specific	NULL
,	NULL
nuclear	NULL
extracts	NULL
prepared	NULL
from	NULL
the	NULL
human	NULL
T-cell	NULL
line	NULL
Jurkat	NULL
and	NULL
from	NULL
several	NULL
PMA/ionomycin-stimulated	NULL
hematopoietic	NULL
cell	NULL
lines	NULL
were	NULL
From	NULL
www	NULL
.	NULL

bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

ROLE	NULL
OF	NULL
THE	NULL
ACT-1	NULL
SITE	NULL
IN	NULL
IL-3	NULL
EXPRESSION	NULL
<	NULL
“	NULL
Lu	NULL
``	NULL
+159	NULL
138	NULL
e	NULL
ACT-1	NULL
a	NULL
b	NULL
c	NULL
d	NULL
a	NULL
+151	NULL
142	NULL
3	NULL
931	NULL
~159	NULL
~147	NULL
lene	NULL
5	NULL
Fig	NULL
3	NULL
.	NULL

The	NULL
ACT-1	NULL
site	NULL
and	NULL
the	NULL
ARRE-1	NULL
site	NULL
in	NULL
the	NULL
IL-2	NULL
promoter	NULL
bind	NULL
proteins	NULL
with	NULL
similar	NULL
specificities	NULL
.	NULL

Probes	NULL
are	NULL
indicated	NULL
under	NULL
each	NULL
panel	NULL
.	NULL

Constitutive	NULL
(	NULL
solid	NULL
arrow	NULL
)	NULL
and	NULL
inducible	NULL
bindings	NULL
(	NULL
open	NULL
arrow	NULL
)	NULL
are	NULL
indicated	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Binding	NULL
to	NULL
ACT-1	NULL
by	NULL
nuclear	NULL
extracts	NULL
of	NULL
stimulated	NULL
MLA144	NULL
in	NULL
the	NULL
absence	NULL
(	NULL
lane	NULL
a	NULL
)	NULL
or	NULL
presence	NULL
(	NULL
lanes	NULL
b	NULL
through	NULL
e	NULL
)	NULL
of	NULL
competitor	NULL
.	NULL

Lane	NULL
b	NULL
,	NULL
ACT-1	NULL
competitor	NULL
(	NULL
-159	NULL
,	NULL
-138	NULL
)	NULL
;	NULL
lane	NULL
c	NULL
,	NULL
octamer	NULL
consensus	NULL
sequence	NULL
(	NULL
ATGCAAAT	NULL
)	NULL
;	NULL
lane	NULL
d	NULL
,	NULL
NFIL-2D	NULL
Oct-1-binding	NULL
sequence	NULL
(	NULL
ATGAATTA	NULL
)	NULL
;	NULL
and	NULL
lane	NULL
e	NULL
,	NULL
NIP-binding	NULL
site	NULL
(	NULL
TCCTCTCACCTGCTGCCATGCTTCCCATCT	NULL
}	NULL
,	NULL
an	NULL
unrelated	NULL
competitor	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Binding	NULL
by	NULL
nuclear	NULL
extracts	NULL
prepared	NULL
from	NULL
stimulated	NULL
Jurkat	NULL
cells	NULL
to	NULL
the	NULL
3	NULL
'	NULL
probe	NULL
(	NULL
-151	NULL
,	NULL
-142	NULL
)	NULL
in	NULL
the	NULL
absence	NULL
(	NULL
lanes	NULL
a	NULL
and	NULL
d	NULL
)	NULL
or	NULL
presence	NULL
(	NULL
lanes	NULL
b	NULL
and	NULL
c	NULL
)	NULL
of	NULL
anti-Oct-1	NULL
antiserum	NULL
.	NULL

Lane	NULL
a	NULL
,	NULL
no	NULL
competitor	NULL
;	NULL
lane	NULL
b	NULL
,	NULL
no	NULL
competitor	NULL
,	NULL
antiserum	NULL
added	NULL
30	NULL
minutes	NULL
after	NULL
probe	NULL
;	NULL
lane	NULL
c	NULL
,	NULL
no	NULL
competitor	NULL
,	NULL
antiserum	NULL
added	NULL
30	NULL
minutes	NULL
before	NULL
probe	NULL
;	NULL
lane	NULL
d	NULL
,	NULL
3	NULL
competitor	NULL
(	NULL
-151	NULL
,	NULL
-142	NULL
)	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Binding	NULL
to	NULL
the	NULL
5¢	NULL
probe	NULL
(	NULL
-159	NULL
,	NULL
-147	NULL
)	NULL
by	NULL
stimulated	NULL
MLA144	NULL
nuclear	NULL
extracts	NULL
in	NULL
the	NULL
absence	NULL
(	NULL
lane	NULL
a	NULL
)	NULL
or	NULL
presence	NULL
of	NULL
competitor	NULL
sites	NULL
(	NULL
lanes	NULL
b	NULL
through	NULL
d	NULL
)	NULL
.	NULL

Lane	NULL
b	NULL
,	NULL
5¢	NULL
(	NULL
-159	NULL
,	NULL
-147	NULL
)	NULL
competitor	NULL
;	NULL
lane	NULL
c	NULL
,	NULL
OAP	NULL
site	NULL
competitor	NULL
(	NULL
TTTGAAAA-TATGTGTAATATG	NULL
)	NULL
from	NULL
the	NULL
IL-2	NULL
promoter	NULL
;	NULL
lane	NULL
d	NULL
,	NULL
nonspecific	NULL
oligonucleotide	NULL
competitor	NULL
(	NULL
-97	NULL
,	NULL
-61	NULL
)	NULL
of	NULL
the	NULL
IL-3	NULL
promoter	NULL
.	NULL

assayed	NULL
for	NULL
a	NULL
nuclear	NULL
factor	NULL
that	NULL
would	NULL
bind	NULL
the	NULL
5	NULL
'	NULL
probe	NULL
(	NULL
Fig	NULL
2B	NULL
and	NULL
C	NULL
)	NULL
.	NULL

Only	NULL
in	NULL
Jurkat	NULL
cells	NULL
did	NULL
activation	NULL
result	NULL
in	NULL
IL-3	NULL
expression	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
inducible	NULL
binding	NULL
activity	NULL
was	NULL
present	NULL
in	NULL
stimulated	NULL
Jurkat	NULL
cells	NULL
(	NULL
Fig	NULL
2B	NULL
)	NULL
.	NULL

Although	NULL
many	NULL
other	NULL
bands	NULL
can	NULL
be	NULL
seen	NULL
,	NULL
they	NULL
represent	NULL
nonspecific	NULL
binding	NULL
as	NULL
they	NULL
do	NULL
not	NULL
compete	NULL
with	NULL
excess	NULL
unlabeled	NULL
probe	NULL
(	NULL
lane	NULL
c	NULL
)	NULL
and	NULL
their	NULL
intensity	NULL
varies	NULL
from	NULL
experiment	NULL
to	NULL
experiment	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
inducible	NULL
complex	NULL
was	NULL
not	NULL
observed	NULL
in	NULL
other	NULL
cell	NULL
lines	NULL
(	NULL
Fig	NULL
2C	NULL
,	NULL
lanes	NULL
a	NULL
through	NULL
f	NULL
)	NULL
,	NULL
with	NULL
the	NULL
possible	NULL
exception	NULL
of	NULL
U937	NULL
cells	NULL
(	NULL
lane	NULL
e	NULL
)	NULL
,	NULL
in	NULL
which	NULL
a	NULL
weak	NULL
complex	NULL
was	NULL
found	NULL
to	NULL
comigrate	NULL
with	NULL
the	NULL
inducible	NULL
binding	NULL
detected	NULL
in	NULL
MLA	NULL
144	NULL
cells	NULL
(	NULL
lane	NULL
g	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
nuclear	NULL
extracts	NULL
from	NULL
human	NULL
fibroblasts	NULL
,	NULL
similarly	NULL
assayed	NULL
,	NULL
displayed	NULL
no	NULL
binding	NULL
to	NULL
the	NULL
5	NULL
'	NULL
probe	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
nuclear	NULL
factor	NULL
that	NULL
binds	NULL
to	NULL
this	NULL
5	NULL
'	NULL
site	NULL
is	NULL
inducible	NULL
,	NULL
and	NULL
appears	NULL
to	NULL
be	NULL
T-cell	NULL
specific	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
the	NULL
constitutive	NULL
binding	NULL
over	NULL
the	NULL
3	NULL
'	NULL
probe	NULL
occurs	NULL
in	NULL
Raji	NULL
,	NULL
K562	NULL
,	NULL
and	NULL
U937	NULL
cells	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

That	NULL
complex	NULL
is	NULL
neither	NULL
stimulation	NULL
dependent	NULL
nor	NULL
T-cell	NULL
specific	NULL
.	NULL

As	NULL
a	NULL
nuclear	NULL
factor	NULL
that	NULL
is	NULL
present	NULL
in	NULL
multiple	NULL
cell	NULL
lines	NULL
,	NULL
the	NULL
constitutive	NULL
factor	NULL
may	NULL
be	NULL
a	NULL
known	NULL
DNA-binding	NULL
protein	NULL
.	NULL

The	NULL
sequence	NULL
of	NULL
its	NULL
binding	NULL
site	NULL
was	NULL
therefore	NULL
studied	NULL
for	NULL
sequence	NULL
homologies	NULL
with	NULL
known	NULL
nuclear	NULL
factor-binding	NULL
elements	NULL
.	NULL

The	NULL
closest	NULL
homologies	NULL
noted	NULL
were	NULL
with	NULL
the	NULL
sequence	NULL
between	NULL
-	NULL
149	NULL
through	NULL
-141	NULL
on	NULL
the	NULL
noncoding	NULL
strand	NULL
.	NULL

Five	NULL
of	NULL
eight	NULL
nucleotide	NULL
matches	NULL
were	NULL
identified	NULL
with	NULL
several	NULL
known	NULL
octamer-binding	NULL
sites	NULL
.	NULL

These	NULL
include	NULL
the	NULL
published	NULL
octamer-binding	NULL
consensus	NULL
sequence	NULL
(	NULL
ATGCAAAT	NULL
)	NULL
``	NULL
'	NULL
as	NULL
well	NULL
as	NULL
the	NULL
two	NULL
Oct-l-binding	NULL
sites	NULL
present	NULL
in	NULL
the	NULL
human	NULL
IL-2	NULL
promoter	NULL
,	NULL
namely	NULL
,	NULL
NFIL-2D	NULL
(	NULL
ATGAATTA	NULL
)	NULL
and	NULL
ARRE-1	NULL
(	NULL
ATGTAAAA	NULL
)	NULL
.	NULL

*	NULL
``	NULL
Having	NULL
made	NULL
this	NULL
observation	NULL
,	NULL
we	NULL
tested	NULL
the	NULL
binding	NULL
of	NULL
the	NULL
ACT-1	NULL
constitutive	NULL
factor	NULL
to	NULL
oligonucleotides	NULL
of	NULL
these	NULL
sequences	NULL
.	NULL

The	NULL
results	NULL
,	NULL
shown	NULL
in	NULL
Fig	NULL
3A	NULL
,	NULL
demonstrate	NULL
that	NULL
binding	NULL
of	NULL
the	NULL
constitutive	NULL
factor	NULL
is	NULL
competed	NULL
by	NULL
the	NULL
Oct-1	NULL
consensus	NULL
sequence	NULL
(	NULL
lane	NULL
c	NULL
)	NULL
and	NULL
is	NULL
partially	NULL
competed	NULL
by	NULL
the	NULL
NFIL-2D	NULL
sequence	NULL
(	NULL
lane	NULL
d	NULL
)	NULL
.	NULL

Binding	NULL
is	NULL
not	NULL
competed	NULL
by	NULL
a	NULL
nonspecific	NULL
oligonucleotide	NULL
sequence	NULL
(	NULL
lane	NULL
e	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
constitutive	NULL
factor	NULL
shares	NULL
an	NULL
affinity	NULL
for	NULL
the	NULL
same	NULL
DNA	NULL
binding	NULL
sites	NULL
as	NULL
Oct-1	NULL
.	NULL

To	NULL
confirm	NULL
that	NULL
the	NULL
constitutive	NULL
factor	NULL
is	NULL
an	NULL
octamer-binding	NULL
protein	NULL
,	NULL
we	NULL
obtained	NULL
antiserum	NULL
known	NULL
to	NULL
react	NULL
with	NULL
Oct-1	NULL
.	NULL

The	NULL
antiserum	NULL
was	NULL
added	NULL
to	NULL
a	NULL
mobility	NULL
shift	NULL
reaction	NULL
with	NULL
stimulated	NULL
Jurkat	NULL
cell	NULL
nuclear	NULL
extract	NULL
either	NULL
before	NULL
or	NULL
after	NULL
addition	NULL
of	NULL
the	NULL
3	NULL
'	NULL
probe	NULL
.	NULL

Figure	NULL
3B	NULL
demonstrates	NULL
that	NULL
the	NULL
antiserum	NULL
blocks	NULL
binding	NULL
of	NULL
the	NULL
constitutive	NULL
factor	NULL
to	NULL
the	NULL
probe	NULL
(	NULL
lanes	NULL
b	NULL
and	NULL
c	NULL
)	NULL
.	NULL

Addition	NULL
of	NULL
this	NULL
antiserum	NULL
under	NULL
the	NULL
same	NULL
conditions	NULL
had	NULL
no	NULL
effect	NULL
on	NULL
the	NULL
binding	NULL
of	NULL
the	NULL
repressor	NULL
NIP	NULL
complex	NULL
to	NULL
its	NULL
cognate	NULL
probe	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
the	NULL
inhibition	NULL
of	NULL
binding	NULL
is	NULL
specific	NULL
to	NULL
the	NULL
constitutive	NULL
factor	NULL
,	NULL
suggesting	NULL
that	NULL
the	NULL
anti-Oct-1	NULL
antibody	NULL
interacts	NULL
with	NULL
it	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
binding	NULL
of	NULL
the	NULL
inducible	NULL
,	NULL
T-cell-specific	NULL
factor	NULL
to	NULL
the	NULL
5	NULL
'	NULL
probe	NULL
is	NULL
neither	NULL
competed	NULL
by	NULL
octamer	NULL
binding	NULL
se-quences	NULL
,	NULL
nor	NULL
affected	NULL
by	NULL
anti-Oct-l	NULL
antiserum	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Although	NULL
this	NULL
factor	NULL
is	NULL
distinct	NULL
from	NULL
Oct-1	NULL
,	NULL
its	NULL
binding	NULL
From	NULL
www	NULL
.	NULL

bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

932	NULL
site	NULL
is	NULL
physically	NULL
linked	NULL
to	NULL
an	NULL
octamer-binding	NULL
site	NULL
,	NULL
an	NULL
arrangement	NULL
that	NULL
is	NULL
analogous	NULL
to	NULL
the	NULL
ARRE-1	NULL
element	NULL
that	NULL
participates	NULL
in	NULL
the	NULL
inducible	NULL
expression	NULL
of	NULL
IL-2	NULL
by	NULL
T	NULL
cells	NULL
.	NULL

This	NULL
raised	NULL
the	NULL
possibility	NULL
that	NULL
the	NULL
two	NULL
sites	NULL
might	NULL
share	NULL
similar	NULL
protein-binding	NULL
specificities	NULL
.	NULL

Indeed	NULL
,	NULL
when	NULL
the	NULL
OAP	NULL
binding	NULL
site	NULL
of	NULL
the	NULL
IL-2	NULL
promoter	NULL
is	NULL
used	NULL
as	NULL
a	NULL
competitor	NULL
for	NULL
binding	NULL
to	NULL
the	NULL
ACT-1	NULL
5	NULL
probe	NULL
,	NULL
it	NULL
works	NULL
as	NULL
efficiently	NULL
as	NULL
the	NULL
5	NULL
'	NULL
probe	NULL
itself	NULL
(	NULL
Fig	NULL
3C	NULL
,	NULL
lanes	NULL
b	NULL
and	NULL
c	NULL
)	NULL
.	NULL

Functional	NULL
assays	NULL
.	NULL

-	NULL
Functionally	NULL
,	NULL
the	NULL
ACT-1	NULL
element	NULL
is	NULL
known	NULL
to	NULL
upregulate	NULL
the	NULL
inducible	NULL
expression	NULL
of	NULL
the	NULL
IL-3	NULL
gene	NULL
.	NULL

To	NULL
determine	NULL
the	NULL
individual	NULL
roles	NULL
of	NULL
the	NULL
two	NULL
distinct	NULL
binding	NULL
elements	NULL
,	NULL
we	NULL
transiently	NULL
transfected	NULL
into	NULL
MLA	NULL
144	NULL
cells	NULL
a	NULL
reporter	NULL
gene	NULL
linked	NULL
to	NULL
selectively	NULL
mutated	NULL
IL-3	NULL
promoter	NULL
sequences	NULL
and	NULL
assayed	NULL
for	NULL
the	NULL
level	NULL
of	NULL
inducible	NULL
expression	NULL
of	NULL
the	NULL
reporter	NULL
gene	NULL
mRNA	NULL
.	NULL

Because	NULL
the	NULL
activity	NULL
of	NULL
the	NULL
AP-1	NULL
and	NULL
NIP	NULL
elements	NULL
may	NULL
overshadow	NULL
the	NULL
effects	NULL
of	NULL
the	NULL
individual	NULL
ACT-1	NULL
elements	NULL
on	NULL
the	NULL
level	NULL
of	NULL
reporter	NULL
gene	NULL
expression	NULL
,	NULL
constructs	NULL
were	NULL
made	NULL
that	NULL
did	NULL
not	NULL
include	NULL
AP-1	NULL
or	NULL
NIP	NULL
.	NULL

To	NULL
this	NULL
end	NULL
,	NULL
the	NULL
promoter	NULL
was	NULL
truncated	NULL
at	NULL
position	NULL
-173	NULL
.	NULL

Figure	NULL
4	NULL
shows	NULL
that	NULL
the	NULL
-173	NULL
promoter	NULL
is	NULL
sufficient	NULL
to	NULL
promote	NULL
IL-3	NULL
expression	NULL
(	NULL
lane	NULL
a	NULL
)	NULL
.	NULL

Expression	NULL
of	NULL
this	NULL
construct	NULL
was	NULL
not	NULL
observed	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
MLA	NULL
144	NULL
cell	NULL
activation	NULL
or	NULL
when	NULL
it	NULL
was	NULL
introduced	NULL
into	NULL
stimulated	NULL
fibroblasts	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

When	NULL
the	NULL
ACT	NULL
-1	NULL
element	NULL
in	NULL
this	NULL
construct	NULL
is	NULL
replaced	NULL
with	NULL
a	NULL
BamHI	NULL
linker	NULL
,	NULL
expression	NULL
is	NULL
completely	NULL
lost	NULL
(	NULL
lane	NULL
b	NULL
)	NULL
,	NULL
suggesting	NULL
that	NULL
ACT-1	NULL
,	NULL
as	NULL
a	NULL
whole	NULL
,	NULL
is	NULL
an	NULL
essential	NULL
positive	NULL
regulatory	NULL
element	NULL
within	NULL
the	NULL
first	NULL
173	NULL
bp	NULL
of	NULL
the	NULL
promoter	NULL
.	NULL

When	NULL
the	NULL
constitutive	NULL
factor	NULL
binding	NULL
site	NULL
(	NULL
nt	NULL
-146	NULL
through	NULL
-139	NULL
)	NULL
is	NULL
replaced	NULL
by	NULL
a	NULL
BamHI	NULL
linker	NULL
(	NULL
lane	NULL
c	NULL
)	NULL
,	NULL
the	NULL
level	NULL
of	NULL
IL-3	NULL
expression	NULL
is	NULL
equivalent	NULL
to	NULL
that	NULL
seen	NULL
with	NULL
the	NULL
intact	NULL
-173	NULL
construct	NULL
.	NULL

Truncation	NULL
of	NULL
the	NULL
promoter	NULL
at	NULL
position	NULL
-149	NULL
,	NULL
which	NULL
leaves	NULL
intact	NULL
the	NULL
constitutive	NULL
element	NULL
but	NULL
deletes	NULL
the	NULL
inducible	NULL
element	NULL
of	NULL
ACT	NULL
-1	NULL
,	NULL
decreases	NULL
by	NULL
half	NULL
the	NULL
expression	NULL
observed	NULL
with	NULL
the	NULL
-173	NULL
construct	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Together	NULL
,	NULL
these	NULL
transient	NULL
transfection	NULL
and	NULL
DNA-binding	NULL
experiments	NULL
point	NULL
to	NULL
the	NULL
5	NULL
half	NULL
of	NULL
ACT-1	NULL
as	NULL
a	NULL
key	NULL
element	NULL
in	NULL
the	NULL
inducible	NULL
,	NULL
T-cell-specific	NULL
expression	NULL
of	NULL
IL-3	NULL
.	NULL

The	NULL
role	NULL
of	NULL
the	NULL
3	NULL
'	NULL
,	NULL
constitutive	NULL
element	NULL
is	NULL
less	NULL
clear	NULL
;	NULL
however	NULL
,	NULL
taken	NULL
in	NULL
the	NULL
context	NULL
of	NULL
the	NULL
whole	NULL
-315	NULL
promoter	NULL
,	NULL
which	NULL
includes	NULL
the	NULL
AP-1	NULL
and	NULL
NIP	NULL
elements	NULL
,	NULL
it	NULL
plays	NULL
a	NULL
noticeable	NULL
role	NULL
in	NULL
maximizing	NULL
IL-3	NULL
expression	NULL
.	NULL

When	NULL
the	NULL
constitutive	NULL
site	NULL
is	NULL
replaced	NULL
with	NULL
a	NULL
BamHI	NULL
linker	NULL
in	NULL
an	NULL
otherwise	NULL
intact	NULL
-315	NULL
promoter	NULL
construct	NULL
(	NULL
lane	NULL
e	NULL
)	NULL
,	NULL
there	NULL
is	NULL
a	NULL
decrease	NULL
in	NULL
IL-3	NULL
expression	NULL
as	NULL
compared	NULL
with	NULL
the	NULL
level	NULL
of	NULL
expression	NULL
of	NULL
the	NULL
wild-type	NULL
-315	NULL
construct	NULL
(	NULL
lane	NULL
d	NULL
)	NULL
.	NULL

Interestingly	NULL
,	NULL
no	NULL
further	NULL
reduction	NULL
in	NULL
expression	NULL
is	NULL
observed	NULL
when	NULL
the	NULL
whole	NULL
ACT	NULL
-1	NULL
site	NULL
in	NULL
the	NULL
-315	NULL
promoter	NULL
is	NULL
replaced	NULL
by	NULL
a	NULL
BamHI	NULL
linker	NULL
(	NULL
lanes	NULL
f	NULL
and	NULL
g	NULL
)	NULL
.	NULL

No	NULL
expression	NULL
of	NULL
the	NULL
-315	NULL
construct	NULL
was	NULL
detected	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
stimulation	NULL
or	NULL
after	NULL
introduction	NULL
into	NULL
fibroblasts®	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

DISCUSSION	NULL
IL-3	NULL
is	NULL
involved	NULL
in	NULL
the	NULL
hematopoietic	NULL
response	NULL
to	NULL
antigenic	NULL
challenge	NULL
by	NULL
causing	NULL
proliferation	NULL
and	NULL
differentiation	NULL
of	NULL
early	NULL
precursors	NULL
of	NULL
multiple	NULL
hematopoietic	NULL
cell	NULL
lines	NULL
.	NULL

It	NULL
seems	NULL
likely	NULL
that	NULL
dysregulation	NULL
of	NULL
IL-3	NULL
expression	NULL
may	NULL
be	NULL
responsible	NULL
for	NULL
one	NULL
or	NULL
more	NULL
disorders	NULL
of	NULL
hematopoiesis	NULL
.	NULL

To	NULL
be	NULL
able	NULL
to	NULL
recognize	NULL
dysregulation	NULL
of	NULL
IL-3	NULL
expression	NULL
,	NULL
one	NULL
must	NULL
first	NULL
understand	NULL
the	NULL
normal	NULL
regulatory	NULL
controls	NULL
affecting	NULL
its	NULL
expres-	NULL
DAVIES	NULL
ET	NULL
AL	NULL
sion	NULL
.	NULL

Because	NULL
IL-3	NULL
expression	NULL
is	NULL
regulated	NULL
in	NULL
part	NULL
at	NULL
the	NULL
level	NULL
of	NULL
transcription	NULL
,	NULL
we	NULL
have	NULL
directed	NULL
our	NULL
research	NULL
toward	NULL
discovering	NULL
the	NULL
molecular	NULL
basis	NULL
of	NULL
IL-3	NULL
gene	NULL
regulation	NULL
at	NULL
the	NULL
level	NULL
of	NULL
the	NULL
promoter	NULL
.	NULL

The	NULL
ACT-1	NULL
(	NULL
or	NULL
NF-IL3-A	NULL
)	NULL
element	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
mediate	NULL
inducible	NULL
and	NULL
T-cell-specific	NULL
expression	NULL
of	NULL
IL-3	NULL
and	NULL
to	NULL
be	NULL
a	NULL
site	NULL
of	NULL
nuclear	NULL
factor	NULL
binding	NULL
.	NULL

It	NULL
binds	NULL
not	NULL
one	NULL
but	NULL
two	NULL
nuclear	NULL
factors	NULL
.	NULL

The	NULL
more	NULL
5°	NULL
part	NULL
of	NULL
the	NULL
element	NULL
binds	NULL
an	NULL
inducible	NULL
factor	NULL
detected	NULL
thus	NULL
far	NULL
only	NULL
in	NULL
stimulated	NULL
T	NULL
cells	NULL
.	NULL

An	NULL
oligonucleotide	NULL
directed	NULL
against	NULL
the	NULL
DNA-binding	NULL
site	NULL
of	NULL
OAP	NULL
in	NULL
the	NULL
IL-2	NULL
promoter	NULL
can	NULL
efficiently	NULL
compete	NULL
for	NULL
its	NULL
binding	NULL
to	NULL
the	NULL
IL-3	NULL
probe	NULL
.	NULL

The	NULL
more	NULL
3	NULL
'	NULL
part	NULL
binds	NULL
a	NULL
constitutive	NULL
factor	NULL
present	NULL
in	NULL
both	NULL
unstimulated	NULL
and	NULL
stimulated	NULL
T	NULL
cells	NULL
and	NULL
also	NULL
present	NULL
in	NULL
all	NULL
other	NULL
cell	NULL
lines	NULL
assayed	NULL
.	NULL

This	NULL
constitutive	NULL
factor	NULL
appears	NULL
to	NULL
be	NULL
Oct-1	NULL
or	NULL
a	NULL
closely	NULL
related	NULL
protein	NULL
.	NULL

The	NULL
binding	NULL
characteristics	NULL
of	NULL
ACT-1	NULL
are	NULL
therefore	NULL
reminiscent	NULL
of	NULL
those	NULL
of	NULL
the	NULL
ARRE-1	NULL
site	NULL
in	NULL
the	NULL
IL-2	NULL
promoter	NULL
,	NULL
``	NULL
which	NULL
will	NULL
be	NULL
discussed	NULL
later	NULL
.	NULL

The	NULL
functional	NULL
roles	NULL
of	NULL
the	NULL
inducible	NULL
and	NULL
constitutive	NULL
binding	NULL
sites	NULL
are	NULL
somewhat	NULL
complex	NULL
.	NULL

We	NULL
have	NULL
found	NULL
that	NULL
mutation	NULL
of	NULL
the	NULL
whole	NULL
ACT-1	NULL
element	NULL
(	NULL
nt	NULL
-154	NULL
through	NULL
-139	NULL
)	NULL
within	NULL
an	NULL
otherwise	NULL
intact	NULL
-315	NULL
promoter	NULL
diminishes	NULL
but	NULL
does	NULL
not	NULL
ablate	NULL
IL-3	NULL
expression	NULL
.	NULL

Yet	NULL
,	NULL
the	NULL
same	NULL
mutation	NULL
in	NULL
the	NULL
-173	NULL
promoter	NULL
does	NULL
result	NULL
in	NULL
complete	NULL
loss	NULL
of	NULL
gene	NULL
expression	NULL
.	NULL

To	NULL
evaluate	NULL
the	NULL
functional	NULL
roles	NULL
of	NULL
the	NULL
two	NULL
sites	NULL
within	NULL
ACT-1	NULL
,	NULL
without	NULL
the	NULL
added	NULL
complexity	NULL
of	NULL
the	NULL
upstream	NULL
elements	NULL
,	NULL
we	NULL
examined	NULL
the	NULL
functional	NULL
activity	NULL
of	NULL
several	NULL
truncated	NULL
promoters	NULL
that	NULL
had	NULL
been	NULL
mutated	NULL
at	NULL
selected	NULL
sites	NULL
.	NULL

When	NULL
the	NULL
constitutive	NULL
binding	NULL
site	NULL
is	NULL
selectively	NULL
mutated	NULL
in	NULL
the	NULL
context	NULL
of	NULL
the	NULL
-173	NULL
promoter	NULL
,	NULL
the	NULL
ability	NULL
of	NULL
the	NULL
promoter	NULL
to	NULL
induce	NULL
gene	NULL
expression	NULL
is	NULL
not	NULL
diminished	NULL
in	NULL
comparison	NULL
to	NULL
the	NULL
intact	NULL
-173	NULL
promoter	NULL
.	NULL

The	NULL
role	NULL
of	NULL
the	NULL
constitutive	NULL
site	NULL
is	NULL
only	NULL
apparent	NULL
when	NULL
the	NULL
full	NULL
promoter	NULL
is	NULL
used	NULL
.	NULL

That	NULL
role	NULL
seems	NULL
to	NULL
be	NULL
a	NULL
cooperative	NULL
one	NULL
with	NULL
other	NULL
promoter	NULL
elements	NULL
to	NULL
maximize	NULL
IL-3	NULL
expression	NULL
.	NULL

The	NULL
organization	NULL
and	NULL
function	NULL
of	NULL
the	NULL
ACT	NULL
site	NULL
show	NULL
striking	NULL
parallels	NULL
with	NULL
those	NULL
of	NULL
the	NULL
ARRE-1	NULL
site	NULL
in	NULL
the	NULL
IL-2	NULL
promoter	NULL
.	NULL

As	NULL
noted	NULL
earlier	NULL
,	NULL
the	NULL
constitutive	NULL
site	NULL
appears	NULL
to	NULL
bind	NULL
Oct-1	NULL
or	NULL
a	NULL
related	NULL
octamer-binding	NULL
protein	NULL
.	NULL

Like	NULL
IL-3	NULL
,	NULL
IL-2	NULL
is	NULL
a	NULL
cytokine	NULL
expressed	NULL
only	NULL
by	NULL
activated	NULL
T	NULL
cells	NULL
.	NULL

ARRE-1	NULL
is	NULL
a	NULL
site	NULL
that	NULL
constitutively	NULL
binds	NULL
Oct-	NULL
!	NULL

over	NULL
its	NULL
3	NULL
'	NULL
part	NULL
and	NULL
inducibly	NULL
binds	NULL
a	NULL
second	NULL
protein	NULL
(	NULL
OAP	NULL
)	NULL
over	NULL
its	NULL
5	NULL
'	NULL
part	NULL
.	NULL

This	NULL
similarity	NULL
in	NULL
binding	NULL
behavior	NULL
takes	NULL
on	NULL
added	NULL
importance	NULL
as	NULL
we	NULL
demonstrate	NULL
that	NULL
the	NULL
T-cell-specific	NULL
,	NULL
inducible	NULL
factor	NULL
that	NULL
binds	NULL
ACT-1	NULL
recognizes	NULL
the	NULL
OAP	NULL
``	NULL
-binding	NULL
site	NULL
of	NULL
ARRE-1	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
the	NULL
two	NULL
factors	NULL
appear	NULL
to	NULL
be	NULL
functionally	NULL
related	NULL
.	NULL

When	NULL
ARRE-	NULL
!	NULL

is	NULL
isolated	NULL
from	NULL
the	NULL
other	NULL
elements	NULL
of	NULL
the	NULL
promoter	NULL
,	NULL
OAP	NULL
binding	NULL
but	NULL
not	NULL
Oct-1	NULL
binding	NULL
is	NULL
important	NULL
for	NULL
efficient	NULL
,	NULL
inducible	NULL
expression	NULL
of	NULL
a	NULL
reporter	NULL
gene	NULL
.	NULL
``	NULL

However	NULL
,	NULL
in	NULL
the	NULL
context	NULL
of	NULL
the	NULL
full	NULL
IL-2	NULL
promoter	NULL
,	NULL
the	NULL
Oct-1	NULL
site	NULL
and	NULL
the	NULL
OAP	NULL
site	NULL
are	NULL
almost	NULL
equivalent	NULL
in	NULL
their	NULL
contribution	NULL
to	NULL
promoting	NULL
gene	NULL
transcription	NULL
.	NULL

However	NULL
,	NULL
there	NULL
is	NULL
one	NULL
notable	NULL
difference	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
the	NULL
Oct-1-facilitated	NULL
binding	NULL
of	NULL
OAP	NULL
to	NULL
the	NULL
ARRE-1	NULL
site	NULL
,	NULL
we	NULL
have	NULL
not	NULL
been	NULL
able	NULL
to	NULL
see	NULL
the	NULL
inducible	NULL
and	NULL
constitutive	NULL
complexes	NULL
bind	NULL
simultaneously	NULL
to	NULL
the	NULL
same	NULL
ACT	NULL
probe	NULL
.	NULL

This	NULL
may	NULL
suggest	NULL
that	NULL
the	NULL
inducible	NULL
factor	NULL
and	NULL
OAP	NULL
``	NULL
may	NULL
be	NULL
different	NULL
proteins	NULL
.	NULL

Alternatively	NULL
,	NULL
nucleotide	NULL
differences	NULL
in	NULL
the	NULL
binding	NULL
sequences	NULL
between	NULL
the	NULL
two	NULL
promoters	NULL
may	NULL
dictate	NULL
different	NULL
binding	NULL
af-finities	NULL
.	NULL

From	NULL
www	NULL
.	NULL

bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

ROLE	NULL
OF	NULL
THE	NULL
ACT-1	NULL
SITE	NULL
IN	NULL
IL-3	NULL
EXPRESSION	NULL
933	NULL
s	NULL
Act	NULL
<	NULL
AP-1	NULL
NIP	NULL
$	NULL
3	NULL
A	NULL
I	NULL
I	NULL
1	NULL
300	NULL
-200	NULL
100	NULL
Fig	NULL
4	NULL
.	NULL

-	NULL
Role	NULL
of	NULL
ACT-1	NULL
and	NULL
its	NULL
components	NULL
in	NULL
IL-3	NULL
expression	NULL
.	NULL

The	NULL
226-nt	NULL
band	NULL
(	NULL
solid	NULL
arrow	NULL
)	NULL
corresponds	NULL
to	NULL
transcripts	NULL
from	NULL
the	NULL
reporter	NULL
gene	NULL
,	NULL
and	NULL
the	NULL
151-nt	NULL
fragment	NULL
(	NULL
open	NULL
arrow	NULL
)	NULL
corresponds	NULL
to	NULL
endogenous	NULL
gibbon	NULL
IL-3	NULL
transcript	NULL
.	NULL

The	NULL
latter	NULL
band	NULL
serves	NULL
as	NULL
internal	NULL
control	NULL
for	NULL
RNA	NULL
loading	NULL
and	NULL
T-cell	NULL
activation	NULL
.	NULL

Promoter	NULL
constructs	NULL
,	NULL
labeled	NULL
a	NULL
through	NULL
g	NULL
,	NULL
are	NULL
diagrammed	NULL
and	NULL
tested	NULL
in	NULL
their	NULL
respective	NULL
lanes	NULL
.	NULL

Mutations	NULL
are	NULL
denoted	NULL
by	NULL
dotted	NULL
lines	NULL
.	NULL

Lane	NULL
a	NULL
,	NULL
-173	NULL
construct	NULL
;	NULL
lane	NULL
b	NULL
,	NULL
-173	NULL
construct	NULL
with	NULL
ACT-1	NULL
(	NULL
-154	NULL
,	NULL
-139	NULL
)	NULL
replaced	NULL
by	NULL
6-nt	NULL
linker	NULL
;	NULL
lane	NULL
c	NULL
,	NULL
-173	NULL
construct	NULL
with	NULL
constitutive	NULL
site	NULL
(	NULL
-146	NULL
,	NULL
-139	NULL
)	NULL
replaced	NULL
by	NULL
6-nt	NULL
linker	NULL
;	NULL
lane	NULL
d	NULL
,	NULL
-315	NULL
construct	NULL
;	NULL
lane	NULL
e	NULL
,	NULL
-315	NULL
construct	NULL
with	NULL
constitutive	NULL
site	NULL
(	NULL
-146	NULL
,	NULL
-139	NULL
)	NULL
replaced	NULL
by	NULL
6-nt	NULL
linker	NULL
;	NULL
lane	NULL
f	NULL
,	NULL
-315	NULL
construct	NULL
;	NULL
lane	NULL
g	NULL
,	NULL
-315	NULL
construct	NULL
with	NULL
ACT-1	NULL
(	NULL
-154	NULL
,	NULL
-139	NULL
)	NULL
replaced	NULL
by	NULL
6-nt	NULL
linker	NULL
.	NULL

Lanes	NULL
a	NULL
through	NULL
c	NULL
,	NULL
d	NULL
and	NULL
e	NULL
,	NULL
and	NULL
f	NULL
and	NULL
g	NULL
represent	NULL
independent	NULL
RNase	NULL
protection	NULL
experiments	NULL
.	NULL

The	NULL
close	NULL
relationship	NULL
between	NULL
the	NULL
ACT-1	NULL
and	NULL
ARRE-1	NULL
elements	NULL
both	NULL
in	NULL
terms	NULL
of	NULL
binding	NULL
and	NULL
function	NULL
for	NULL
the	NULL
regulated	NULL
expression	NULL
of	NULL
IL-3	NULL
and	NULL
IL-2	NULL
,	NULL
respectively	NULL
,	NULL
is	NULL
only	NULL
one	NULL
such	NULL
parallel	NULL
.	NULL

Several	NULL
cis-acting	NULL
elements	NULL
of	NULL
the	NULL
IL-3	NULL
promoter	NULL
appear	NULL
to	NULL
be	NULL
functionally	NULL
dependent	NULL
on	NULL
one	NULL
another	NULL
to	NULL
op-timally	NULL
regulate	NULL
gene	NULL
expression	NULL
.	NULL

This	NULL
is	NULL
a	NULL
pattern	NULL
that	NULL
is	NULL
surfacing	NULL
in	NULL
many	NULL
promoter	NULL
systems	NULL
.	NULL

Again	NULL
,	NULL
comparison	NULL
between	NULL
the	NULL
IL-3	NULL
and	NULL
IL-2	NULL
promoters	NULL
shows	NULL
that	NULL
,	NULL
although	NULL
they	NULL
do	NULL
not	NULL
share	NULL
significant	NULL
sequence	NULL
homologies	NULL
,	NULL
they	NULL
do	NULL
share	NULL
a	NULL
common	NULL
arrangement	NULL
of	NULL
similar	NULL
binding	NULL
elements	NULL
.	NULL

In	NULL
par-ticular	NULL
,	NULL
they	NULL
each	NULL
contain	NULL
a	NULL
module	NULL
characterized	NULL
by	NULL
an	NULL
AP-1	NULL
site	NULL
upstream	NULL
,	NULL
an	NULL
octamer/octamer-associated	NULL
protein	NULL
site	NULL
(	NULL
ACT-1	NULL
and	NULL
ARRE-1	NULL
)	NULL
downstream	NULL
,	NULL
and	NULL
a	NULL
negative	NULL
regulatory	NULL
element	NULL
in	NULL
the	NULL
middle	NULL
(	NULL
NIP	NULL
and	NULL
NRE-A	NULL
)	NULL
.	NULL
``	NULL

This	NULL
shared	NULL
pattern	NULL
of	NULL
regulatory	NULL
elements	NULL
may	NULL
be	NULL
at	NULL
the	NULL
core	NULL
of	NULL
the	NULL
shared	NULL
regulatory	NULL
mechanisms	NULL
by	NULL
which	NULL
T-cell	NULL
activation	NULL
induces	NULL
transcription	NULL
of	NULL
these	NULL
genes	NULL
.	NULL

Elements	NULL
not	NULL
shared	NULL
by	NULL
the	NULL
two	NULL
promoters	NULL
may	NULL
result	NULL
in	NULL
the	NULL
differences	NULL
in	NULL
regulation	NULL
of	NULL
the	NULL
two	NULL
genes	NULL
.	NULL

In	NULL
the	NULL
IL-3	NULL
promoter	NULL
,	NULL
the	NULL
AP-1	NULL
site	NULL
and	NULL
the	NULL
inducible	NULL
site	NULL
in	NULL
ACT-1	NULL
have	NULL
somewhat	NULL
redundant	NULL
functions	NULL
,	NULL
but	NULL
these	NULL
functions	NULL
appear	NULL
to	NULL
augment	NULL
one	NULL
another	NULL
in	NULL
the	NULL
intact	NULL
promoter	NULL
.	NULL

The	NULL
repressor	NULL
element	NULL
between	NULL
AP-1	NULL
and	NULL
ACT-1	NULL
also	NULL
interacts	NULL
with	NULL
these	NULL
other	NULL
promoter	NULL
elements	NULL
.	NULL

Furthermore	NULL
,	NULL
there	NULL
appear	NULL
to	NULL
be	NULL
elements	NULL
downstream	NULL
of	NULL
ACT-1	NULL
,	NULL
as	NULL
yet	NULL
uncharacterized	NULL
,	NULL
that	NULL
may	NULL
influence	NULL
the	NULL
function	NULL
of	NULL
these	NULL
other	NULL
elements	NULL
.	NULL

The	NULL
multiple	NULL
regulatory	NULL
sites	NULL
with	NULL
overlapping	NULL
and	NULL
interdependent	NULL
functions	NULL
certainly	NULL
must	NULL
be	NULL
crucial	NULL
for	NULL
maintaining	NULL
the	NULL
tight	NULL
control	NULL
over	NULL
gene	NULL
expression	NULL
that	NULL
is	NULL
necessary	NULL
for	NULL
the	NULL
important	NULL
biologic	NULL
role	NULL
that	NULL
IL-3	NULL
and	NULL
IL-2	NULL
play	NULL
in	NULL
controlling	NULL
hematopoiesis	NULL
and	NULL
T-cell	NULL
pro-liferation	NULL
,	NULL
respectively	NULL
.	NULL

ACKNOWLEDGMENT	NULL
We	NULL
are	NULL
very	NULL
grateful	NULL
to	NULL
Drs	NULL
K.S	NULL
.	NULL

Ullman	NULL
and	NULL
G.R	NULL
.	NULL

Crabtree	NULL
(	NULL
Stanford	NULL
University	NULL
)	NULL
for	NULL
their	NULL
generous	NULL
gift	NULL
of	NULL
mouse	NULL
anti-Oct-1	NULL
antibody	NULL
.	NULL

REFERENCES	NULL
1	NULL
.	NULL

Sief	NULL
CA	NULL
:	NULL
Hematopoietic	NULL
growth	NULL
factors	NULL
.	NULL

J	NULL
Clin	NULL
Invest	NULL
79:1	NULL
549	NULL
,	NULL
1987	NULL
2	NULL
.	NULL

Clark	NULL
SC	NULL
,	NULL
Kamen	NULL
R	NULL
:	NULL
The	NULL
human	NULL
hematopoietic	NULL
colony-stim-ulating	NULL
factors	NULL
.	NULL

Science	NULL
236:1229	NULL
,	NULL
1987	NULL
3	NULL
.	NULL

Niemeyer	NULL
CM	NULL
,	NULL
Sieff	NULL
CA	NULL
,	NULL
Mathey-Prevot	NULL
B	NULL
,	NULL
Wimperis	NULL
JZ	NULL
,	NULL
Bierer	NULL
BE	NULL
,	NULL
Clark	NULL
SC	NULL
,	NULL
Nathan	NULL
DG	NULL
:	NULL
Expression	NULL
of	NULL
human	NULL
interleukin-3	NULL
(	NULL
multi-CSF	NULL
)	NULL
is	NULL
restricted	NULL
to	NULL
human	NULL
lymphocytes	NULL
and	NULL
T	NULL
cell	NULL
tumor	NULL
lines	NULL
.	NULL

Blood	NULL
73:945	NULL
,	NULL
1989	NULL
4	NULL
.	NULL

Ryan	NULL
GR	NULL
,	NULL
Milton	NULL
SE	NULL
,	NULL
Lopez	NULL
AF	NULL
,	NULL
Bardy	NULL
PG	NULL
,	NULL
Vadas	NULL
MA	NULL
,	NULL
Shannon	NULL
MF	NULL
:	NULL
Human	NULL
interleukin-3	NULL
mRNA	NULL
accumulation	NULL
is	NULL
controlled	NULL
at	NULL
both	NULL
the	NULL
transcriptional	NULL
and	NULL
posttranscriptional	NULL
level	NULL
.	NULL

Blood	NULL
77	NULL
:	NULL
1195	NULL
,	NULL
1991	NULL
5	NULL
.	NULL

Taniguchi	NULL
T	NULL
:	NULL
Regulation	NULL
of	NULL
cytokine	NULL
gene	NULL
expression	NULL
.	NULL

Ann	NULL
Rev	NULL
Immunol	NULL
6:439	NULL
,	NULL
1988	NULL
6	NULL
.	NULL

Mathey-Prevot	NULL
B	NULL
,	NULL
Andrews	NULL
NC	NULL
,	NULL
Murphy	NULL
HS	NULL
,	NULL
Kreissman	NULL
SG	NULL
,	NULL
Nathan	NULL
DG	NULL
:	NULL
Positive	NULL
and	NULL
negative	NULL
elements	NULL
regulate	NULL
human	NULL
interleukin	NULL
3	NULL
expression	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
87:5046	NULL
,	NULL
1990	NULL
From	NULL
www	NULL
.	NULL

bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

934	NULL
7	NULL
.	NULL

Shoemaker	NULL
SG	NULL
,	NULL
Hromas	NULL
R	NULL
,	NULL
Kaushansky	NULL
K	NULL
:	NULL
Transcriptional	NULL
regulation	NULL
of	NULL
interleukin	NULL
3	NULL
gene	NULL
expression	NULL
in	NULL
T	NULL
lymphocytes	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
87:9650	NULL
,	NULL
1990	NULL
8	NULL
,	NULL
Ullman	NULL
KS	NULL
,	NULL
Flanagan	NULL
WM	NULL
,	NULL
Edwards	NULL
CA	NULL
,	NULL
Crabtree	NULL
GR	NULL
:	NULL
Activation	NULL
of	NULL
early	NULL
gene	NULL
expression	NULL
in	NULL
T	NULL
lymphocytes	NULL
by	NULL
Oct-1	NULL
and	NULL
an	NULL
inducible	NULL
protein	NULL
,	NULL
OAP	NULL
.	NULL

Science	NULL
254:558	NULL
,	NULL
1991	NULL
9	NULL
.	NULL

Dignam	NULL
JD	NULL
,	NULL
Lebowitz	NULL
RM	NULL
,	NULL
Roeder	NULL
RG	NULL
:	NULL
Accurate	NULL
transcription	NULL
initiation	NULL
by	NULL
RNA	NULL
polymerase	NULL
II	NULL
in	NULL
a	NULL
soluble	NULL
extract	NULL
from	NULL
isolated	NULL
mammalian	NULL
nuclei	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
11:1475	NULL
,	NULL
1983	NULL
10	NULL
.	NULL

Martin	NULL
DIL	NULL
,	NULL
Tsai	NULL
SF	NULL
,	NULL
Orkin	NULL
SH	NULL
:	NULL
Increased	NULL
gamma-globin	NULL
DAVIES	NULL
ET	NULL
AL	NULL
expression	NULL
in	NULL
a	NULL
nondeletion	NULL
HPFH	NULL
mediated	NULL
by	NULL
an	NULL
erythroid-specific	NULL
DNA-binding	NULL
factor	NULL
.	NULL

Nature	NULL
338:435	NULL
,	NULL
1989	NULL
11	NULL
.	NULL

Mitchell	NULL
PJ	NULL
,	NULL
Tjian	NULL
R	NULL
:	NULL
Transcriptional	NULL
regulation	NULL
in	NULL
mammalian	NULL
cells	NULL
by	NULL
sequence-specific	NULL
DNA	NULL
binding	NULL
proteins	NULL
.	NULL

Science	NULL
245:371	NULL
,	NULL
1989	NULL
12	NULL
.	NULL

Shibuya	NULL
H	NULL
,	NULL
Taniguchi	NULL
T	NULL
:	NULL
Identification	NULL
of	NULL
multiple	NULL
cis-elements	NULL
and	NULL
trans-acting	NULL
factors	NULL
involved	NULL
in	NULL
the	NULL
induced	NULL
expression	NULL
of	NULL
human	NULL
IL-2	NULL
gene	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
17:9173	NULL
,	NULL
1989	NULL
13	NULL
.	NULL

Williams	NULL
TM	NULL
,	NULL
Moolten	NULL
D	NULL
,	NULL
Burlein	NULL
J	NULL
,	NULL
Romano	NULL
J	NULL
,	NULL
Bhaerman	NULL
R	NULL
,	NULL
Godillot	NULL
A	NULL
,	NULL
Mellon	NULL
M	NULL
,	NULL
Rauscher	NULL
FJ	NULL
,	NULL
Kant	NULL
JA	NULL
:	NULL
Identification	NULL
of	NULL
a	NULL
zinc	NULL
finger	NULL
protein	NULL
that	NULL
inhibits	NULL
IL-2	NULL
gene	NULL
expression	NULL
.	NULL

Science	NULL
254:1791	NULL
,	NULL
1991	NULL
From	NULL
www	NULL
.	NULL

by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

blood	NULL
===	NULL
Interleukin-3	NULL
expression	NULL
by	NULL
activated	NULL
T	NULL
cells	NULL
involves	NULL
an	NULL
inducible	NULL
,	NULL
T-cell-specific	NULL
factor	NULL
and	NULL
an	NULL
octamer	NULL
binding	NULL
protein	NULL
K	NULL
Davies	NULL
,	NULL
EC	NULL
TePas	NULL
,	NULL
DG	NULL
Nathan	NULL
and	NULL
B	NULL
Mathey-Prevot	NULL
ETY	NULL
Op	NULL
~	NULL
2	NULL
A	NULL
gs	NULL
%	NULL
,	NULL
'	NULL
.	NULL

:	NULL
e	NULL
@	NULL
.	NULL

2	NULL
(	NULL
f	NULL
Updated	NULL
information	NULL
and	NULL
services	NULL
can	NULL
be	NULL
found	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.bloodjournal.org/content/81/4/928.full.html	NULL
Articles	NULL
on	NULL
similar	NULL
topics	NULL
can	NULL
be	NULL
found	NULL
in	NULL
the	NULL
following	NULL
Blood	NULL
collections	NULL
Information	NULL
about	NULL
reproducing	NULL
this	NULL
article	NULL
in	NULL
parts	NULL
or	NULL
in	NULL
its	NULL
entirety	NULL
may	NULL
be	NULL
found	NULL
online	NULL
at	NULL
:	NULL
requests	NULL
Information	NULL
about	NULL
ordering	NULL
reprints	NULL
may	NULL
be	NULL
found	NULL
online	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.bloodjournal.org/site/misc/rights.xhtml	NULL
#	NULL
reprints	NULL
Information	NULL
about	NULL
subscriptions	NULL
and	NULL
ASH	NULL
membership	NULL
may	NULL
be	NULL
found	NULL
online	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.bloodjournal.org/site/subscriptions/index.xhtml	NULL
Blood	NULL
(	NULL
print	NULL
ISSN	NULL
0006-4971	NULL
,	NULL
online	NULL
ISSN	NULL
1528-0020	NULL
)	NULL
,	NULL
is	NULL
published	NULL
weekly	NULL
by	NULL
the	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
,	NULL
2021	NULL
L	NULL
St	NULL
,	NULL
NW	NULL
,	NULL
Suite	NULL
900	NULL
,	NULL
Washington	NULL
DC	NULL
20036	NULL
.	NULL

Copyright	NULL
2011	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
;	NULL
all	NULL
rights	NULL
reserved	NULL
.	NULL

